Last updated: May 25, 2026
Back to directoryCompare products by workflow fit, risk tier, review boundary, and the first source-backed claims to verify before a pilot.
| Product | Regulatory / FDA | Privacy | Evidence | Workflow |
|---|---|---|---|---|
| OpenEvidence | Treat as clinician-facing medical information and clinical reference support unless a deployment uses it for patient-specific clinical decision support that changes regulatory obligations. | Check user eligibility, PHI-entry policy, HIPAA-aligned processing claims, retention, sponsorship or network-profile terms, and whether organization-level agreements are available. | Verify every answer against the displayed citations and confirm which licensed journals, guidelines, or source partnerships are available for the clinical question. | Best governed as fast evidence lookup for verified clinicians, with local rules for patient-specific prompts, citation review, and documentation of decisions made outside the tool. |
| ClinicalKey AI | Treat as clinician-facing clinical reference and decision-support software; verify whether local use remains non-device CDS or creates regulated obligations because patient context and clinical recommendations may be involved. | Review HIPAA-compliant claims, encryption, query history, pseudonymized support access, institutional license terms, and whether prompts or patient details are shared with model or cloud partners. | Confirm the answer cites current licensed content that actually supports the claim, and sample high-risk specialty questions before trusting it in point-of-care workflows. | Best governed as a clinician-reviewed evidence lookup layer with local rules for patient-specific prompts, citation checking, flagged answers, and documentation outside the product. |
| UpToDate Expert AI | Treat as high-risk clinician-facing clinical decision support; confirm whether the exact use remains reference support or becomes regulated patient-specific CDS in the deployment setting. | Review UpToDate terms before entering patient context, because public terms restrict personal data and PHI for Expert AI; enterprise agreements may differ and should be checked directly. | Validate that each answer links to current UpToDate topics that support the recommendation, and sample complex specialty cases for assumptions, omissions, and hallucination handling. | Best governed as a clinician-reviewed UpToDate search layer with local rules for PHI, source checking, documentation, escalation, and when to consult primary guidelines or specialists. |
| Dyna AI | Treat as high-risk clinical decision-support retrieval rather than autonomous care; review whether local use remains clinician reference support and how DynaMed Decisions or shared-decision tools are separated. | Check institutional contract terms, because public AI terms prohibit HIPAA-protected or similar medical data input into AI tools and place responsibility for output review on the user. | Verify answers against DynaMed, DynaMedex, or Dynamic Health source links, update timestamps, and specialty coverage before using output in point-of-care decisions. | Best governed as a switchable AI/search mode inside existing EBSCO clinical content workflows, with clinician review, source checking, query reruns, and documentation outside the tool. |
| Glass Health | Treat differential diagnosis and plan drafting as high-risk clinical decision support; verify intended use, supervision, and whether any local deployment creates regulated CDS obligations. | Confirm what patient context may be entered, how cases are stored, whether enterprise privacy terms are available, and how API or ambient features handle PHI. | Check whether recommendations cite current evidence, guidelines, and local standards, then audit generated differentials and plans against clinician judgment. | Use as a draft reasoning aid only, with clinician revision before anything enters the chart, orders, referral decisions, or patient instructions. |
| Consensus | Treat as research and education support, not clinical decision support or a diagnostic system. | Avoid entering patient-identifiable information unless contract and privacy terms explicitly support the use case. | Verify database coverage, study filters, Consensus Meter interpretation, and whether each cited paper supports the generated answer. | Best for literature discovery, study triage, and student or writer workflows where users manually review the underlying papers. |
| Elicit | Treat as literature-review and evidence-synthesis workflow software rather than patient-care decision support. | Use de-identified literature and project materials unless enterprise terms explicitly cover confidential or patient-related documents. | Validate search recall, screening decisions, extraction fields, source quotes, and PRISMA-style audit trail on the review topic before relying on outputs. | Best for systematic-review teams that keep human reviewer reconciliation, protocol documentation, and final appraisal outside the automation. |
| Scite | Treat as research support and citation-context analysis, not clinical decision support. | Avoid uploading PHI or confidential manuscripts unless the subscription and privacy terms cover that workflow. | Check coverage for the specialty, how citation statements are classified, and whether assistant summaries match the cited source context. | Best for claim checking, literature mapping, and manuscript review where humans still appraise study quality and clinical relevance. |
| Atropos Health | Treat as high-governance evidence generation and clinical-reference support; verify whether local use affects care decisions enough to trigger CDS, IRB, data-use, or policy review. | Confirm whether questions use local EHR data, federated network data, or de-identified inputs, then review data-use agreements, PHI handling, and Microsoft or EHR integration terms. | Require methods transparency for each real-world evidence report, including cohort definition, source network, statistical approach, uncertainty, and literature support. | Best for health systems and life-sciences teams that can route outputs through clinician, methods, data-governance, or medical-affairs review before action. |
| Doximity Ask | Treat as clinician workflow support unless a local deployment uses it for regulated clinical decision support; verify intended-use claims before point-of-care reliance. | Doximity states HIPAA-compliant protocols, PHI support, and encryption in transit and at rest; confirm contract, retention, audit, and enterprise controls for organization use. | Support materials say responses can use referenced evidence and preferred journals; clinicians still need to check sources and hallucination warnings. | Best evaluated as a clinician-authenticated assistant for first drafts, education, translation, document review, and clinical reference inside Doximity. |
| AvoMD | Treat as clinical decision support whose risk depends on the pathway, calculator, automation, and intended use; verify whether any local workflow needs FDA, SaMD, or institutional CDS review. | Review PHI flow through EHR integration, prompts, analytics, user access, retention, vendor subprocessors, BAA terms, and security documentation before enabling patient-context workflows. | Require current guideline sources, local approver records, logic transparency, test cases, and monitoring for outdated or unsafe pathway behavior. | Best deployed through a clinical governance process with named pathway owners, version control, clinician override paths, and staged rollout monitoring. |
| Causaly | Treat as biomedical research and R&D decision-support infrastructure unless a deployment supports regulated submissions or care decisions; then require study-specific validation, audit, and compliance review. | Review enterprise terms for internal documents, private data, third-party data, AI-agent access, retention, customer IP, and any patient-derived or confidential dataset before deployment. | Validate factual grounding, source traceability, graph provenance, no-answer behavior, and expert-review requirements for each target assessment, indication search, or regulatory-evidence workflow. | Best governed as a repeatable scientific research workspace with named reviewers, versioned evidence packages, documented assumptions, and escalation for uncertain or unsupported conclusions. |
| Abridge | Position it as clinician documentation support unless a local workflow extends it into coding, prior authorization, or other regulated decision support that needs separate review. | Review the contract path for BAA terms, recording consent, retention, training-data use, and security documentation from the trust center before piloting with PHI. | Pilot with specialty-specific encounters and measure missing facts, hallucinated text, source-to-note provenance, and clinician edit burden. | Best evaluated where note provenance, clinician review, and direct EHR insertion are required inside enterprise documentation workflows. |
| Ambience Healthcare | Treat it primarily as documentation and revenue-support workflow software unless local use expands into clinical guidance or order support that changes the review burden. | Confirm how PHI is processed under customer agreements, whether a BAA applies, and how recordings, transcripts, and downstream chart data are retained and secured. | Validate specialty-specific documentation, coding, and CDI performance on real encounters before expanding beyond a controlled pilot. | Most relevant for organizations that want one vendor spanning chart prep, ambient capture, note generation, and post-visit documentation tasks inside supported EHR workflows. |
| Nuance DAX Copilot | Treat it as documentation support rather than autonomous clinical decision support unless a connected workflow adds higher-risk reasoning or coding automation. | Review Azure-hosting, recording, retention, HITRUST/security documentation, and the exact Microsoft or Nuance contract path for PHI handling and business-associate terms. | Measure documentation quality, specialty fit, review burden, and any vendor-published productivity claims against your own clinician pilot. | Best suited to organizations already aligned with Dragon, Microsoft Cloud for Healthcare, and supported EHR insertion workflows. |
| Microsoft Dragon Copilot | Treat documentation as lower-to-medium risk, but review radiology reporting, coding suggestions, order capture, and decision-support features separately because each can change regulatory and clinical accountability. | Review Microsoft healthcare contract terms, Azure/security documentation, recording and transcript retention, EHR integration permissions, third-party reference content, and business-associate coverage before PHI use. | Validate Dragon Copilot's output against real specialty encounters, radiology reports, nurse flowsheet workflows, and cited medical references instead of relying on broad productivity claims. | Best governed as a role-specific clinical workspace with local configuration, clinician review, EHR insertion checks, and separate approval for automation beyond note drafting. |
| Oracle Health Clinical AI Agent | Treat chart review and care-related summaries as higher-risk clinical decision support because outputs use patient-specific EHR data; planned administrative or patient-facing features need separate intended-use review. | Review Oracle Health security materials, EHR access permissions, audit logging, incident reporting, data residency, and contract terms before enabling patient-specific workflows. | Validate source links, summary completeness, missed data, hallucinated facts, and workflow-specific recommendations against representative charts before clinicians rely on outputs. | Best governed as an embedded EHR agent with role-based permissions, source review, clinician judgment, exception escalation, and clear separation between live and planned functionality. |
| AWS HealthScribe | Treat it as documentation infrastructure for draft notes; review the finished application, specialty scope, EHR insertion, and any clinical-decision or coding extensions separately. | Design PHI controls across the full AWS workflow, including BAA eligibility, S3 storage, customer-managed keys, IAM, retention, logging, application databases, and downstream EHR integrations. | Use transcript evidence mapping during pilots and measure factual completeness, factual correctness, speaker attribution, omitted observations, hallucinated text, and performance under noisy or complex encounters. | Best governed as a builder platform with explicit clinician review, correction capture, exception handling for unsupported visits, and monitoring for audio-quality and specialty-specific failure modes. |
| Suki | Treat it as clinician workflow support unless a local deployment leans on reasoning or coding features as unsupervised clinical decision support. | Review HIPAA, security, BAA, recording-consent, and webhook or integration controls for the exact deployment model you plan to use. | Pilot documentation quality, coding assistance, and any Q&A features separately because each workflow carries a different verification burden. | Most useful where voice-enabled documentation, edits, and EHR-connected assistant actions need to fit into clinician-controlled workflows. |
| Nabla | Use it as clinician documentation support unless your deployment expands into higher-risk clinical reasoning or patient-specific decision support. | Verify no-audio-storage defaults, feedback-data handling, chosen hosting region, BAA or regional privacy terms, and the exact scope of security certifications. | Pilot on specialty language, multiple speakers, accents, and complex visits instead of assuming general scribe performance transfers to your setting. | Best for teams comparing lighter-weight scribe adoption against enterprise governance requirements and supported EHR integrations. |
| DeepScribe | Treat it as documentation and coding-support software unless a local workflow relies on it for unsupervised clinical interpretation. | Review privacy-policy scope, PHI-handling terms, encryption, role-based access, audit practices, and any BAA obligations before production use. | Validate complex specialty encounters, longitudinal context handling, coding suggestions, and oncology-specific workflows with manual review. | Most relevant for specialty practices that need pre-charting context plus ambient documentation rather than generic transcript-only scribing. |
| Freed | Treat it as draft documentation support, not autonomous clinical documentation or coding submission. | Confirm HIPAA or BAA terms, audio-retention settings, account controls, and whether the planned workflow fits local privacy policy before entering PHI. | Use a small pilot to measure note completeness, specialty fit, and clinician correction burden instead of assuming consumer-like ease means clinical readiness. | Best for individual clinicians or smaller practices that need a simpler scribe workflow before evaluating heavier enterprise integrations. |
| Heidi Health | Separate documentation, evidence, and communications workflows because risk changes if users move from scribing into clinical-reference or patient-facing tasks. | Review regional privacy terms, retention, consent, and any de-identified data-improvement rights before using the broader platform with PHI. | Test the exact Heidi product in scope and measure note quality, evidence reliability, or communications safety separately rather than treating the suite as one workflow. | Best for teams that want configurable clinician tooling but can govern product-by-product rollout across scribe, evidence, and communication features. |
| ModMed Scribe | Treat it as specialty documentation and coding-support software unless downstream automation crosses into unsupervised clinical or billing action. | Review how native EHR integration changes PHI scope, recording-consent workflow, retention, and access controls for your specialty deployment. | Validate specialty note quality and coding suggestions in the real EMA workflow before trusting downstream automation or specialty-specific claims. | Best for specialty groups where built-in EMA integration matters more than a standalone ambient scribe with broader EHR reach. |
| Augmedix | Treat Augmedix as documentation workflow support unless a local implementation adds coding, ordering, or clinical decision functionality that changes intended use. | Hybrid human-assisted models require extra review of workforce access, offshore or subcontractor handling, recording consent, retention, and BAA terms beyond generic AI-scribe checks. | Pilot each mode separately because AI-only and human-assisted documentation can differ in turnaround time, note quality, clinician edits, and operational cost. | Best evaluated where teams need a governed documentation operating model rather than only a self-serve scribe app. |
| Commure Ambient AI | Treat documentation as lower-to-medium risk, but separately review AI Assistant, CareCues, autonomous coding, and revenue-cycle features because each can change clinical, coding, or compliance accountability. | Confirm BAA path, HIPAA scope, audio and transcript retention, training-data use, clinician preference learning, EHR access, audit logs, and subcontractor controls before using PHI. | Validate note quality, specialty fit, coding cue accuracy, prior-history summarization, and generated care-plan content against real encounters before expanding. | Best governed as EHR-connected clinician support with explicit consent, clinician editing, final signoff, exception queues, and separate approval for coding or billing automation. |
| Tali AI | Treat Tali as draft documentation and dictation support unless a deployment adds clinical advice, coding automation, or patient-facing use that changes review obligations. | Review the exact regional product terms for audio deletion, transcript retention, data residency, BAA or data-processing agreement coverage, subprocessors, and model-training restrictions. | Validate note accuracy, specialty terminology, hallucinated facts, missing negatives, and template fit on local encounters before using generated notes at scale. | Best governed as a clinician-controlled scribe with recording consent, draft status, final signoff, EHR insertion checks, and documented correction tracking. |
| Twofold Health | Treat as clinician-reviewed note drafting, not autonomous diagnosis, therapy assessment, coding, or treatment planning without a professional review boundary. | Behavioral health and therapy use needs extra review of consent language, psychotherapy-note segregation, minimum necessary access, BAA terms, retention, and deletion workflow. | Test session-note quality across visit lengths, modalities, speakers, and required formats, with specific review for invented findings or inappropriate therapy-plan language. | Best governed as a draft-note assistant where the clinician controls recording, edits every note, manages EHR transfer, and documents patient consent. |
| TORTUS | Treat TORTUS as documentation support under UK clinical-safety and information-governance review; verify current DTAC, DCB0129/DCB0160, procurement, and local approval status before rollout. | Review UK GDPR lawful basis, processor/controller roles, retention, deletion, subprocessor, security, browser capture, cloud processing, and patient notice requirements. | Validate note and code output against local NHS documentation standards, specialty workflows, clinician edits, safety incidents, and patient opt-out handling. | Best governed as a clinician-reviewed NHS scribe workflow with local DPIA, patient notice, opt-out path, final signoff, and post-deployment safety monitoring. |
| Aidoc | Verify the exact Aidoc algorithm, version, modality, anatomy, intended use, quality-system documentation, and FDA or local authorization before clinical deployment. | Review DICOM routing, AWS or Azure processing, metadata handling, retention, access controls, trust-center evidence, and security documentation for the selected PACS/RIS workflow. | Evaluate performance by finding and site, including false positives, false negatives, alert fatigue, turnaround-time impact, and downstream care-team response. | Best governed as radiology triage and care-coordination support, with radiologist review, escalation rules, and post-deployment monitoring for every enabled module. |
| Viz.ai | Do not treat a platform-level FDA-cleared-algorithm count as clearance for every pathway; verify the specific disease module, indication, and geography. | Check imaging, mobile, messaging, and EHR data flows, including notification content, user access, trust-center controls, retention, and business-associate terms. | Review pathway-specific evidence for time-to-notification, treatment activation, false alerts, missed cases, and outcome measures in comparable hospitals. | Use when the care pathway has named responders, escalation windows, and specialist confirmation rather than as standalone diagnostic interpretation. |
| Ferrum Health | Treat Ferrum as governance and deployment infrastructure; regulatory review still needs model-by-model intended-use, clearance, local-validation, and change-management checks. | Review whether deployment is on-premises, private cloud, or vendor-connected, then verify PHI routing, de-identification, retention, deletion, encryption, access control, BAA, and subprocessor terms. | Require local validation and ongoing monitoring for every model in the catalog, including scanner mix, patient population, drift, false positives, false negatives, and downstream action rates. | Best used when a health system has a clinical AI governance committee, named model owners, incident review, and post-deployment monitoring rather than isolated AI pilots. |
| Blackford Platform | Treat Blackford as deployment infrastructure plus a marketplace; verify regulatory status, intended use, and local authorization for each algorithm routed through it. | Review the on-prem connector, cloud application paths, DICOM metadata, PACS/RIS/EMR links, retention, HITRUST documentation, subprocessors, and customer contract terms. | Evaluate algorithm-level evidence and platform operational metrics separately, including routing accuracy, uptime, failure handling, monitoring, and radiologist interaction. | Best governed as enterprise imaging AI infrastructure with radiology, IT, security, clinical engineering, and governance review before adding each algorithm. |
| Brainomix 360 Stroke | Review each Brainomix module separately because e-ASPECTS, e-CTA, Triage Stroke, core-volume, e-MRI, mobile alerts, and regional releases can carry different indications and clearance status. | Map DICOM transfer, on-premises or cloud processing, pseudonymized mobile notifications, user access, retention period, secure deletion, and customer contract terms before production routing. | Evaluate acute-stroke evidence against the local pathway, including scanner mix, ASPECTS agreement, LVO detection, core-volume estimation, false-positive burden, thrombectomy activation, and transfer outcomes. | Best governed as specialist-reviewed stroke decision support with named responders, escalation windows, downtime handling, audit trails, and post-deployment monitoring for alert quality and treatment delays. |
| Qure.ai | Separate each Qure.ai product and regional deployment because chest X-ray, CT, TB, lung-nodule, and stroke workflows may have different authorization status. | Review image routing, cloud or local deployment, de-identification before cloud processing, retention, public-health data sharing, DICOM metadata handling, and cross-border processing terms. | Validate performance for the target population, prevalence, scanner mix, and clinical pathway, especially when moving from public-health screening into hospital care. | Best evaluated with radiologist or clinician review, escalation rules, and equity monitoring for false positives and false negatives across deployment sites. |
| Rad AI | Treat reporting assistance separately from image-interpretation software; verify whether any local use changes clinical decision-support or quality-system obligations. | Review how dictated findings, report drafts, identifiers, templates, and EHR/RIS data are processed, retained, and used for model improvement. | Pilot against local report templates and modalities, tracking clinically significant omissions, incorrect impressions, turnaround time, and radiologist edit burden. | Best used as radiologist-controlled report drafting where the interpreting physician remains responsible for final report content and QA. |
| Cleerly | Confirm product-specific clearance, Rx-only status, trained-user requirements, indication, eligible CCTA acquisition protocol, and geography before using plaque analysis in a clinical pathway. | Review coronary CTA upload, cloud processing, image retention, report distribution, authorized users, application access, and data-use terms for cardiology workflows. | Evaluate evidence for the intended patient population, scanner protocols, plaque metrics, downstream testing, preventive treatment decisions, and follow-up outcomes. | Best governed as cardiologist-reviewed CCTA analysis feeding structured prevention or treatment-planning workflows, not as autonomous cardiovascular diagnosis. |
| Elucid PlaqueIQ | Match the PlaqueIQ version, 510(k) record, indication, CCTA acquisition requirements, geography, and reimbursement use before adding it to a clinical pathway. | Review coronary CTA upload, remote access to PHI, encrypted transfer, retention, support access, subcontractors, customer-controller obligations, and DPF or local transfer terms. | Assess validation for the target CCTA population, scanner/protocol mix, plaque-composition metrics, lesion-level outputs, reader agreement, and downstream treatment or testing decisions. | Best governed as physician-reviewed coronary CTA plaque analysis feeding structured cardiology risk assessment, prevention, referral, and follow-up workflows. |
| LumineticsCore | Because this is positioned as autonomous diagnostic AI, match use exactly to the FDA-cleared indications, contraindications, trained operators, Topcon camera requirement, and required workflow. | Review retinal-image capture, device connectivity, diagnostic-result hosting, storage, access controls, report delivery, referral communication, and patient-consent documentation. | Monitor unreadable-image rates, false positives, false negatives, referral completion, and local prevalence instead of relying only on clearance status. | Best suited to protocolized diabetic-eye-exam workflows with defined eligibility screening, patient instructions, referral routing, billing, and quality oversight. |
| Eyenuk EyeArt | Match deployment to the current FDA-cleared EyeArt version, indication, supported cameras, trained-user requirements, adult diabetes population, geography, and referral workflow. | Review retinal-image upload, cloud processing, API integrations, EHR/PACS connectivity, encryption, retention, support access, audit logging, BAA terms, and privacy/security contacts before sending PHI. | Validate performance locally across camera model, operator skill, image quality, disease prevalence, patient demographics, false-positive burden, missed-referral risk, and follow-up completion. | Best governed as an autonomous screening workflow with eligibility checks, trained image capture, report review, referral routing, documentation, billing, and post-deployment quality monitoring. |
| RapidAI | Validate the selected RapidAI module against its own clearance, modality, anatomy, and intended use rather than applying platform claims across all workflows. | Review edge, hybrid, on-prem, and cloud deployment choices; PACS/RIS/EHR integration; image routing; mobile notifications; DPF/privacy terms; data retention; uptime; audit logs; and cybersecurity requirements for acute-care use. | Measure pathway-specific impact on notification timing, transfer decisions, false alerts, missed findings, and downstream outcomes during a controlled rollout. | Best deployed where stroke, vascular, hemorrhage, or aortic teams have clear alert ownership, escalation rules, downtime procedures, and monitoring dashboards. |
| Heartflow | Separate FFRCT, plaque, roadmap, and other Heartflow modules because each may have different clearance, indication, contraindication, and reimbursement requirements. | Review CCTA image submission, cloud analysis, report delivery, retention, access controls, and cardiology-record integration before production use. | Assess clinical utility for the target coronary-artery-disease population, scanner protocols, image quality thresholds, downstream testing, and treatment changes. | Best governed as cardiology-reviewed coronary CTA analysis feeding shared decision-making, referral, preventive-care, or cath-lab planning workflows. |
| Ultromics EchoGo | Match the EchoGo Heart Failure version, 510(k) record, indication, product code, geography, and reimbursement workflow before using output in a heart-failure pathway. | Review echocardiography upload flow, cloud or integration partner processing, customer-controller obligations, retention, deletion, access controls, DPO contact path, and support-data handling. | Evaluate HFpEF detection evidence, eligible echo views, image-quality failures, false-positive and false-negative burden, patient population fit, and downstream testing or referral impact. | Best governed as cardiologist-reviewed echo decision support that feeds HFpEF diagnostic workups, structured reporting, and follow-up planning rather than autonomous diagnosis. |
| Gleamer BoneView | Verify BoneView US K222176 and any local CE, Health Canada, or other authorization for the exact module, anatomy, patient age, and clinical site. | Review imaging-data flow, DICOM metadata, pseudonymized patient data, processor/controller roles, subcontractors, security controls, and retention in the deployment contract. | Validate performance on local trauma X-rays, pediatric and adult case mix, fracture type, body region, scanner workflow, false positives, false negatives, and report turnaround. | Best used as a second-reader and prioritization aid inside existing radiology or emergency workflows, with explicit responsibility for accepting, rejecting, and documenting AI marks. |
| iCAD ProFound AI | Verify the exact ProFound module and version because FDA-cleared detection, density, and risk-related features do not share one blanket authorization. | Review mammography image routing, DICOM metadata handling, PACS/viewer integration, cloud or local deployment, retention, access controls, and security documentation. | Check reader-study evidence, breast-density subgroup performance, recall impact, cancer subtype detection, specificity, and whether priors are used in the selected version. | Map where marks, case scores, density output, risk signals, and worklist prioritization appear in the radiologist workflow before clinical use. |
| ScreenPoint Transpara | Verify the exact Transpara module, version, country, modality, and 510(k) or CE status because detection, density, and comparison features should not be treated as one blanket authorization. | Review mammography image routing, DICOM metadata handling, cloud or on-prem deployment, retention, access controls, subprocessors, and business-associate or data-processing terms. | Check evidence for the target screening population, dense-breast subgroup, 2D versus DBT workflow, cancer subtype, recall impact, and radiologist interaction model. | Best governed as radiologist-reviewed mammography support with local rules for when AI marks or scores change read order, second-read strategy, recall decisions, and documentation. |
| Koios DS Breast | Match K212616 or the relevant current clearance to the exact breast ultrasound workflow, patient group, lesion type, and trained interpreting-physician use. | Review ultrasound image transfer, DICOM metadata handling, cloud or local processing, retention, user access, audit logs, and security documentation before sending clinical studies. | Validate CADx performance on local ultrasound equipment, operator mix, lesion prevalence, benign/malignant balance, subgroup representation, and downstream biopsy decisions. | Best used as adjunctive physician-reviewed ultrasound decision support, with explicit documentation of ROI selection, AI output review, BI-RADS reconciliation, and final clinician accountability. |
| Subtle Medical | Treat each Subtle product as a separate imaging device workflow; match clearance, sequence, modality, and intended-use language before changing clinical protocols. | Verify image transfer, cloud or on-prem processing, retention, DICOM metadata handling, business associate terms, access controls, and vendor security materials. | Validate image quality, artifact risk, scan-time or dose claims, and radiologist acceptance on local scanner models, protocols, body regions, and patient populations. | Coordinate radiology, technologist, physicist, PACS, modality, and protocol governance because image-enhancement tools can affect acquisition and interpretation steps. |
| Lunit | Verify the exact Lunit product, version, modality, anatomy, and intended use against FDA, CE/MDR, and local product-registration materials before clinical deployment. | Review image routing, cloud or partner integrations, retention, access controls, DICOM metadata handling, security documentation, and any research or training-data terms. | Require module-level validation for the local population and scanner workflow rather than relying on platform-level publication or site-count claims. | Map radiologist, breast-imaging, pathology, oncology, PACS/RIS, and escalation workflows separately because Lunit's product family spans multiple clinical pathways. |
| annalise.ai | Separate U.S. triage-cleared findings from broader regional Enterprise feature sets; not all findings, reporting features, or regions have the same status. | Review DICOM flow, viewer access, cloud or local deployment, audit logs, retention, and customer security documentation before routing imaging studies. | Evaluate performance by finding, modality, geography, patient population, radiologist workflow, and reporting-time objective instead of treating 100-plus finding coverage as uniform evidence. | Define whether AI output changes reporting order, draft reports, critical-findings escalation, or second-reader behavior, then monitor alert fatigue and missed findings. |
| CureMetrix | Verify cmTriage's FDA-cleared notification-only intended use and do not generalize it to diagnosis, DBT, cmAssist, or any region-specific product without separate clearance review. | Review DICOM routing, cloud processing, hospital-network integration, metadata handling, retention, access controls, and contract terms before routing mammography studies. | Evaluate local breast-density mix, scanner workflow, suspicious-case prioritization, recall impact, and radiologist performance rather than relying only on vendor benchmark claims. | Best treated as breast-imaging worklist prioritization that supports standard radiologist interpretation, with monitoring for alert fatigue and missed suspicious cases. |
| GE HealthCare Caption AI | Separate scan-guidance features, automated measurement software, and the ultrasound hardware because each can have different cleared indications, compatible systems, and trained-user expectations. | Review device connectivity, image and measurement storage, PACS/EHR export, user access, service telemetry, cloud features, retention, and customer security documentation for ultrasound deployments. | Pilot with the target clinician group and patient mix, measuring diagnostic-quality view acquisition, unusable scans, measurement disagreement, credentialing outcomes, and downstream echo utilization. | Best governed as assisted image acquisition and measurement support with explicit credentialing, QA review, escalation for inadequate studies, and qualified clinician interpretation. |
| Butterfly iQ3 | Separate the iQ3 ultrasound system, education tools, workflow software, and gestational-age AI because hardware clearance and AI-tool clearance do not authorize every clinical use. | Review cloud exam storage, device-user identity, mobile-device controls, sharing links, retention, support access, EHR/PACS export, and enterprise data-processing terms. | Validate image quality, measurement reliability, user training outcomes, gestational-age workflow performance, and follow-up completion for the intended care setting. | Best deployed with POCUS governance: operator credentialing, QA overreads, exam protocols, escalation rules, connectivity fallback, and documentation ownership. |
| Pearl Second Opinion | Match the exact Pearl module, 2D or 3D modality, patient age, anatomy, and intended use to FDA and local clearance before using findings in diagnosis or treatment planning. | Review Pearl's data-protection, privacy, BAA, image-retention, support-access, and cross-border processing terms before routing identifiable dental images. | Validate local performance on bitewing, periapical, panoramic, and CBCT workflows separately, including false positives, missed findings, dentist overrides, and patient-education effects. | Best governed as a dentist-reviewed second-reader and patient-communication layer, with clear rules for editing findings and documenting final clinical judgment. |
| Overjet | Review each FDA clearance separately because caries detection, bone-level measurement, pediatric claims, image enhancement, CBCT, payer review, and voice workflows have different intended uses. | Confirm BAA terms, HIPAA policy, encryption, image and PMS-data retention, patient scheduling data handling, vendor access, and payer-provider data boundaries. | Pilot against local dental images and charting standards, tracking missed lesions, extra findings, periodontal measurements, image-enhancement artifacts, and dentist overrides. | Best deployed with dentist review, patient-communication scripts, PMS/imaging integration testing, payer-use separation, and monitoring for over-treatment or inconsistent documentation. |
| VideaAI | Separate FDA-cleared Clinical Assist detections from patient education, voice, claims, dashboard, and operational analytics features that may not share the same intended use. | Review customer agreements, privacy terms, data retention, image/PMS integration, user access, support access, and analytics use before deploying across practices. | Validate per finding and age group on local dental radiographs, including pediatric cases, calculus, PARL, caries, bone level, false positives, and dentist overrides. | Best governed as clinician-reviewed radiograph support with explicit patient-education boundaries, rollout training, and monitoring for treatment-plan and documentation effects. |
| Paige | Verify the exact Paige product, scanner, tissue type, and intended use, especially for prostate workflows that have FDA-authorized claims. | Review whole-slide image storage, cloud processing, LIS links, access controls, retention, and any secondary-use terms before diagnostic deployment. | Validate performance in the local lab across scanner, stain, tissue preparation, case mix, pathologist workflow, and cancer-prevalence differences. | Best used as pathologist-supervised digital pathology support where suspicious regions, exceptions, and final diagnostic responsibility remain reviewable. |
| PathAI | Distinguish AISight image-management, AISight Dx, partner algorithms, and research-only AI tools before treating any workflow as diagnostic. | Review slide storage, cloud hosting, LIS integration, user roles, audit logs, retention, and customer data-use terms for lab operations. | Validate scanner compatibility, image quality, algorithm performance, pathologist review burden, and lab population fit before routine diagnostic use. | Best evaluated as a digital-pathology platform with AI access, requiring lab validation, pathologist signout controls, and clear separation of RUO and diagnostic tools. |
| Ibex Medical Analytics | Verify the specific Galen module, tissue type, geography, scanner, and intended use; do not generalize Ibex's U.S. 510(k), CE-IVD, IVDR, or other regional claims across all cancer workflows. | Use the customer agreement, BAA or regional data-processing terms, DICOM/WSI transfer path, retention, DPF/GDPR controls, access logs, and deployment model rather than the public website privacy policy alone. | Review validation by organ system, stain, scanner, case mix, false-negative risk, biomarker endpoint, and structured-reporting workflow before routine clinical use. | Best governed as pathologist-supervised cancer-diagnostics support with explicit signout responsibility, exception review, LIS/reporting integration, and post-deployment QA. |
| Proscia | Separate Concentriq AP-Dx primary-diagnosis clearance from Concentriq AP, Concentriq LS, third-party AI applications, and research workflows; scanner and specimen limitations matter. | Confirm hosting, storage, scanner ingestion, LIS integration, user roles, collaboration access, retention, audit logs, and contract terms for diagnostic and life-sciences deployments. | Review the multi-site primary-diagnosis study and any AI-application evidence against the lab's scanner, tissue, specimen, pathologist, and workload context. | Best evaluated as a digital-pathology operating layer where primary diagnosis, AI launch, collaboration, and data-science workflows each need separate governance. |
| Aiforia | Match every Aiforia model to its CE-IVD, RUO, PSO, FDA, or local status; EU/EEA diagnostic claims for selected models should not be applied to all suites or markets. | Verify cloud processing, hosting region, slide upload, scanner integration, retention, customer data-processing terms, access controls, audit logs, and whether public website privacy terms are separate from clinical deployment terms. | Assess model-level performance by cancer type, tissue, stain, scanner, biomarker threshold, grade group, case prevalence, and pathologist review burden. | Best used as pathologist-controlled whole-slide image support where overlays, quantitative scores, triage, case review, and final report responsibility remain explicit. |
| Mindpeak | Verify the exact module, intended use, CE-IVD or local status, ISO 13485 scope, and whether the planned workflow is diagnostic, research, pharma, or deployment-specific. | Do not infer PHI terms from the public website privacy policy alone; require customer-contract, hosting, retention, access-control, scanner/LIS integration, and data-use terms. | Review product-specific validation and publications for the tissue, stain, biomarker, scanner, patient population, and scoring threshold used in the lab. | Map how AI hotspots, biomarker scores, tumor regions, and exceptions appear in the pathologist viewer and report before diagnostic use. |
| Aignostics | Treat Atlas H&E-TME as research-use pathology AI unless Aignostics provides product-specific diagnostic authorization for the intended workflow. | Verify customer-contract data handling, GDPR scope, ISO 27001 controls, processing location, retention, deletion, and slide-identification handling before upload. | Review the validation benchmark for each cancer type, tissue segment, cell class, scanner/stain context, and quantitative endpoint used in the research protocol. | Keep outputs in translational research, biomarker discovery, or study-analysis workflows with scientific review rather than clinical reporting. |
| Lumea | Separate Viewer+ primary-diagnosis claims from BxLink, AI marketplace tools, molecular-ordering workflows, and tissue-handling products; each module and partner algorithm needs its own intended-use review. | Review HIPAA/HITECH documentation, endpoint controls for remote pathologists, encryption, authentication, image storage, AI partner integrations, LIS data flow, retention, and customer-contract terms. | Check viewer validation, scanner compatibility, specialty workflow claims, AI partner evidence, molecular-ordering performance, and local turnaround-time or diagnostic-quality metrics. | Best evaluated as a full pathology operating workflow where specimen handling, slide viewing, AI review, molecular ordering, and final signout are mapped together. |
| Visiopharm | Treat each APP independently because diagnostic, IVDR-certified, CE-IVD, RUO, EU/UK, U.S., and partner-integration status can differ by use case. | Verify data-processing agreements, customer-data roles, image storage, cloud or local deployment, research-data sharing, access controls, retention, and partner-platform data paths. | Review APP-level validation for tissue, stain, biomarker threshold, scanner, laboratory population, performance evaluation, and post-market follow-up before clinical use. | Best used where AI outputs remain reviewable inside existing pathology platforms and where lab teams can govern APP selection, batch processing, QA, and signout. |
| Tribun Health | Match CaloPix, TeleSlide, AI Apps, and partner modules to regional FDA, CE, Health Canada, RUO, EULA, and AI Module Terms before diagnostic deployment. | Review hosting, Azure or local storage, remote access, scanner ingestion, LIS/PACS/EHR integration, customer data-processing terms, role access, audit logs, retention, and AI module data flow. | Assess validation and operational evidence for viewer performance, scanner compatibility, AI module accuracy, archive retrieval, second-opinion workflows, and user adoption in comparable labs. | Best evaluated as an image-management and AI-integration platform where pathologist review, second-opinion routing, telepathology, and final signout remain explicit. |
| DoMore Diagnostics Histotype Px Colorectal | Confirm CE-IVD or other local status for the exact version, market, stage II/III colorectal indication, and whether the deployment is diagnostic, research, or platform-enabled. | Review slide upload, hosting, customer-contract data roles, platform-partner processing, retention, access controls, audit trails, and whether oncology data leaves the lab or hospital environment. | Check validation studies, endpoint definitions, patient population, scanner/site diversity, calibration, and whether evidence supports the actual treatment decision under consideration. | Best used as a tumor-board or oncology decision-support input where pathologists and oncologists review the biomarker beside conventional pathology, ctDNA, and guideline-based factors. |
| Regard | Treat as documentation, chart-review, and clinical-insight support; review any suspected-diagnosis or quality-capture workflow that affects diagnosis documentation, coding, or care decisions. | Verify EHR data access, mobile recording, transcript retention, BAA terms, role-based access, audit logs, and whether scribe-app privacy terms differ from the contracted enterprise deployment. | Require patient-record evidence for each recommended diagnosis, medication, history element, or documentation suggestion and monitor clinician acceptance alongside error and query rates. | Best governed as physician-reviewed proactive documentation with explicit override, correction, coding, CDI, and quality-reporting handoffs. |
| Bayesian Health | Treat as high-risk clinical AI or clinical decision support because it can influence recognition and response to patient deterioration; verify intended use, local policy, CDS review, and regulatory posture by module. | Do not rely on marketing-site privacy alone; require customer security documentation, BAA terms, EHR integration details, PHI retention, audit logs, access controls, and analytics-data boundaries. | Review peer-reviewed evidence, local validation, calibration, alert precision, sensitivity, adoption, equity monitoring, and whether outcome claims reproduce in comparable units. | Best deployed with pathway owners, clinician education, response protocols, alert escalation rules, override tracking, and ongoing governance review. |
| Fathom | Usually revenue-cycle automation rather than clinical decision support, but audit any workflow that directly assigns codes, affects claim submission, or changes coder accountability. | Review BAA, HITRUST scope, EHR and billing-system integrations, data retention, access controls, audit logs, and whether customer data is used to tune automation. | Validate automation rate, accuracy, denial impact, specialty coverage, low-confidence routing, and payer-rule behavior on local claims before reducing coder review. | Best deployed with coder QA, exception queues, denial monitoring, and compliance review rather than blanket touchless submission. |
| CodaMetrix | Primarily coding and revenue-cycle automation, but review service-line scope, coder accountability, payer compliance, and any autonomous coding claims before production use. | Verify health-system data ingestion, Epic or EHR connection path, BAA terms, retention, audit trails, access controls, and whether longitudinal clinical context is reused for model improvement. | Require service-line evidence for coding accuracy, denial reduction, turnaround time, ROI, payer-rule updates, and exception routing on local data. | Best for enterprise coding teams that can stage automation by specialty, keep human review for exceptions, and monitor denials, audits, and coder workload. |
| SmarterDx | Treat it as revenue integrity and documentation-support software; review any diagnosis, charge, or appeal recommendation that could affect coding, billing, quality reporting, or clinical documentation obligations. | Do not rely on the public website privacy policy for PHI terms; verify the customer agreement, BAA, retention, access controls, audit logs, and any Smarter Technologies data-sharing path. | Require chart-level evidence for every suggested diagnosis, charge, or appeal argument and monitor revenue lift alongside denial, audit, and compliance outcomes. | Map how findings move from AI review into CDI, coding, physician query, denials, and claim workflows before expanding beyond a controlled pilot. |
| Waystar AltitudeAI | Usually revenue cycle and administrative workflow software, but module-level review matters when outputs influence documentation specificity, coding, patient financial communication, or payer appeals. | Verify BAA, platform security, patient communication consent, EHR and payer connectivity, role-based access, audit logs, and any data-network or AI-training terms for the chosen modules. | Do not generalize platform-level claims; measure each module against local denial rates, reimbursement accuracy, patient AR, query response, coding accuracy, and compliance review outcomes. | Start with a named revenue cycle workflow and define human approval, exception handling, writeback, payer communication, and reporting ownership before automating. |
| Tennr | Usually administrative patient-flow software, but review any workflow that influences patient prioritization, coverage criteria, authorization, or clinical documentation before automation. | Verify the customer agreement, BAA, retention, de-identified data use, access controls, audit logs, and payer/provider communication channels before sending PHI. | Require field-level evidence for extracted referral/order facts, missing-document decisions, payer criteria, and automated actions, then monitor denial and delay outcomes. | Start with one referral or order workflow and define staff approval, exception handling, payer contact, patient contact, writeback, and escalation ownership. |
| AKASA | Treat as revenue-cycle and documentation-integrity support; review any coding, CDI, quality, or authorization recommendation that can affect claims, payer communication, or clinical documentation. | Confirm customer-specific model training, clinical and financial data access, EHR/API/EDI integrations, BAA, SOC 2/NIST/CIS scope, retention, audit logs, and reporting visibility. | Validate evidence-backed recommendations, human expert review, local model tuning, prebill results, denial impact, and quality-reporting effects before scaling. | Best deployed one workflow at a time with explicit review queues for coding, CDI, auth status, claim status, and revenue-cycle research outputs. |
| Notable | Usually administrative automation, but review patient-access, quality, risk, prior-authorization, care-gap, and patient-message workflows for clinical, payer, and consent implications. | Verify customer agreement and BAA terms rather than relying on website privacy language; check patient messaging consent, EHR access, automation logs, retention, and vendor subprocessors. | Measure containment, booking accuracy, care-gap closure, authorization outcomes, no-show reduction, and exception quality against local baselines and patient-complaint data. | Best governed through workflow-specific guardrails that route urgent needs, failed automations, billing disputes, and clinical questions back to staff. |
| Qventus | Primarily operations automation, but review any workflow that changes patient prioritization, discharge timing, contact, or care coordination for clinical governance impact. | The platform depends on EHR and operational data; verify BAA, security documentation, user permissions, patient-contact consent, and audit logging. | Require local baselines and pilot metrics for capacity, throughput, cancellation reduction, follow-up completion, productivity, and exception handling. | Map the exact action loop from prediction to staff task, patient contact, schedule change, EHR update, or escalation before automating. |
| LeanTaaS iQueue | Treat as operational capacity and scheduling decision support; review any configuration that affects patient prioritization, staffing, discharge timing, or access to care with clinical and operational governance. | Verify customer agreement terms for EHR, scheduling, staffing, bed, infusion, and user data; public privacy language separates website data from customer-directed service data. | Ask for workflow-specific evidence in comparable OR, infusion, or inpatient-flow settings and measure local utilization, access, delay, cancellation, overtime, and safety metrics before scaling. | Map who sees each recommendation, who can override it, what can change automatically, and how exceptions are escalated during day-of operations. |
| Iodine AwareCDI | Treat as CDI, coding, and revenue-cycle decision support; review any diagnosis, quality, or reimbursement recommendation that could affect claims, documentation, or payer communication. | Confirm BAA terms, PHI access, aggregation or de-identification rights, EHR data flows, support access, audit logs, retention, and customer-specific service agreements. | Require chart-level evidence for every suggested condition or query and monitor false positives, missed opportunities, denial outcomes, and physician response burden. | Best deployed with CDI and coding review queues, clear query policies, appeal handoffs, and compliance auditing rather than automatic documentation changes. |
| Cohere Health | Treat as payer operations and clinical-policy workflow software; review medical necessity, denial, appeal, CMS-0057 API, delegated review, and payment integrity obligations before production use. | Verify customer BAA terms, PHI upload paths, access controls, encryption, retention, subcontractors, provider portal controls, and whether public website privacy terms differ from contracted platform terms. | Ask for workflow-specific evidence on authorization accuracy, auto-approval quality, reviewer productivity, clinical guideline alignment, appeal outcomes, and provider/member impact in comparable specialties. | Map the full loop from provider request to AI evidence extraction, policy comparison, clinician review, determination, provider communication, appeal, and downstream payment integrity monitoring. |
| Xsolis Dragonfly | Treat as high-impact operations and clinical-policy workflow software because recommendations can affect medical necessity, admission status, concurrent authorization, denials, appeals, and care coordination. | Verify PHI flows from EMR and financial systems, payer-provider data sharing, access controls, retention, audit logging, support access, customer BAA terms, and privacy-policy limitations. | Require evidence for the exact utilization-management workflow and compare local outcomes for accuracy, denials, appeals, LOS, reviewer productivity, and unintended access or equity effects. | Define which recommendations are advisory, which trigger reviewer queues, who signs off, how disagreements are handled, and how payer-provider collaboration is documented. |
| Hippocratic AI | Start by confirming whether the planned agent is limited to outreach, follow-up, access, or workforce support, because Hippocratic AI says its agents do not diagnose or prescribe and excludes some use cases outright. | Do not infer deployment PHI terms from the public website alone; verify the customer contract, call recording, de-identification, retention, access controls, and any HIPAA or security commitments for the actual workflow. | Treat role-specific call examples and large interaction counts as directional only; require workflow-level safety, escalation, completion, patient-experience, and nurse-review metrics in your own population. | Constrain each agent to named tasks with human handoff rules, emergency escalation, age or specialty exclusions, and monitoring before exposing it to patients. |
| Infermedica | Separate the hosted product from the Engine API: Infermedica says the Engine API itself is not intended for direct clinical use and that final device classification depends on the customer-built application and jurisdiction. | The docs say Engine API processes de-identified symptom sets while Platform API can store personal data; verify which mode you are buying, whether anonymous mode is enabled, and how retention and access are handled contractually. | Do not rely on global accuracy or validation claims alone; test triage disposition, language performance, symptom coverage, and false reassurance risk in your local population and care-routing setup. | Decide whether the product is being used for intake, symptom checking, triage, or nurse-support, then define emergency scripts, escalation paths, and who owns the final recommendation. |
| Ubie | Treat as high-risk patient-facing symptom assessment; confirm jurisdiction, intended use, labeling, and whether the deployment changes care-routing or regulated-device obligations. | Review Ubie's collection of health inputs, medication and appointment information, account data, analytics, transfers, retention, and any enterprise agreement before directing patients to it. | Validate triage, possible-cause, and red-flag behavior against local protocols and population needs rather than relying only on global accuracy or publication-count claims. | Use only with clear warnings, emergency instructions, escalation paths, and a plan for how patients move from self-check output to appropriate care. |
| Hyro | Treat Hyro as patient-access infrastructure unless the configured agent starts handling symptoms, medication questions, or clinical guidance that could change the regulatory and clinical accountability profile. | Verify the actual healthcare deployment terms for PHI, patient record access, recordings, SMS or chat retention, Epic or CRM integrations, and any BAA or customer-specific privacy obligations. | Vendor accuracy and ROI claims should be treated as case-study signals only; measure automation, abandonment, handoff quality, incorrect routing, and unsafe-answer rates on your own intents before scaling. | Define exactly which requests are auto-resolved, which are routed, and which require staff takeover so the agent stays within approved access and support boundaries. |
| Infinitus | Treat as healthcare communications and access workflow automation; reassess risk when agents collect symptoms, side effects, adverse events, financial eligibility, or payer denial details that require regulated or staffed follow-up. | Review consent, call recording, transcripts, PHI, identity verification, retention, subprocessors, customer contracts, and BAA coverage before deploying agents into patient, payor, or provider calls. | Validate call-completion, data accuracy, protocol compliance, adverse-event detection, handoff quality, and patient experience on your own call types instead of relying on aggregate platform claims. | Define each call script, forbidden statements, escalation trigger, staff queue, retry behavior, documentation destination, and monitoring owner before scaling agentic calls. |
| Artera Harmony | Treat as patient access and communications infrastructure unless a configured workflow collects symptoms, provides triage-like guidance, or changes clinical escalation. | Review PHI handling, secure versus unsecure channels, consent, retention, EHR/vendor integrations, message content, role access, and provider-specific privacy responsibilities. | Measure no-show, scheduling, intake, billing, response, and staff-time outcomes separately, and test edge cases before adding autonomous voice or text agents. | Map every message source, cadence, channel, escalation path, and staff queue so AI automation does not create duplicate, conflicting, or unsafe patient communications. |
| Fabric | Separate administrative access workflows from symptom gathering, triage, and virtual care, because physician-built clinical logic and routing can carry a different clinical-governance and device-review burden than scheduling alone. | Fabric publishes HIPAA and SOC 2 Type 2 positioning, but you still need the customer contract, access-control design, retention terms, integration boundaries, and patient-consent model for the exact deployment. | Use case studies as a starting point only; validate routing accuracy, symptom-intake safety, scheduling completion, handoff quality, and downstream clinical or access outcomes in your own setting. | Map where symptom collection ends, where routing or virtual care begins, and when a human clinician or access team member must review or take over. |
| Corti | Risk depends on the configured Corti workflow, so separate documentation, coding, prior authorization, and patient-facing agent use before deciding what clinical-governance or regulatory review is required. | Verify regional hosting, PHI retention, voice and transcript controls, subcontractors, customer logging boundaries, and BAA or DPA terms for the specific deployment rather than relying on generic platform claims. | Treat benchmark and launch claims as a starting point only; run workflow-specific tests for escalation, hallucinations, multilingual quality, coding accuracy, and human override burden before production use. | Constrain each agent, model, and tool path to a named job with auditability, handoff rules, and rollback paths so governed deployment remains practical. |
| Sully.ai | Risk varies sharply by agent role; distinguish documentation support, coding extraction, receptionist workflows, triage, and any clinical-advice behavior before deployment. | Verify HIPAA/BAA terms, audio and transcript retention, webhook security, API logging, EHR writeback controls, and subcontractor access. | Do not rely on broad benchmark or marketing claims alone; run role-specific safety tests for notes, coding, patient contact, and escalation. | Constrain each agent to a named job with handoff rules, clinician or staff review, rollback paths, and monitoring before broad rollout. |
| Memora Health | Separate care management, education, symptom collection, remote monitoring, and escalation workflows because patient-facing risk changes by program and message content. | Review SMS consent, PHI in text channels, account and profile retention, subcontractors, customer-contract terms, BAA coverage, opt-out controls, and how any Commure transition affects data governance. | Validate engagement, adherence, symptom escalation, patient satisfaction, and safety outcomes in the specific care program rather than relying on cross-program performance claims. | Best governed as care-team extension software with defined message libraries, escalation paths, queue ownership, after-hours behavior, and clinical review for program updates. |
| Ada Health | Confirm which Ada product and geography are in scope, because Ada positions some enterprise flows as regulated symptom-assessment technology and says jurisdiction-specific limits still need to be verified. | Ada publishes privacy and compliance claims, but the deployment review still needs to cover consent, partner data sharing, retention, automated-decision boundaries, and any HIPAA or regional health-data obligations. | Use published studies and enterprise claims as supporting context only; validate routing accuracy, false reassurance risk, escalation quality, and handover usefulness in your own population and service map. | Define how symptom assessment, care navigation, and clinician or access-team handover connect so users are not left with ambiguous next steps or delayed escalation. |
| Mediktor | Separate symptom assessment, routing, telemedicine support, and LLM-enhanced agent behavior because each deployment can change clinical, regional, and regulated-device obligations. | Review privacy, security, consent, retention, subprocessor, integration, and customer-contract terms before using Mediktor with PHI or patient-identifiable symptom data. | Ask for clinical-validation materials that match the target language, patient population, care setting, acuity distribution, and routing protocol. | Configure it as a bounded digital-front-door workflow with clear service routing, emergency escalation, human handoff, and post-launch safety review. |
| Luma Health Navigator | Treat as patient access and operational automation unless a configured workflow starts making clinical recommendations, handling urgent symptoms, or changing medication/refill decisions. | Review Luma's policy documents, AI data handling claims, voice/SMS data flows, EHR integrations, subprocessors, retention, access controls, and BAA terms for the exact Navigator workflow. | Use public customer outcomes as directional only; validate call automation, patient verification, cancellation accuracy, refill routing, escalation quality, language performance, and safety edge cases locally. | Define each self-service task, fallback path, staff queue, channel switch, patient-identity check, and monitoring owner before letting Navigator resolve patient requests autonomously. |
| Clearstep Smart Care Routing | Treat as high-risk patient-facing triage and routing; verify intended use, jurisdiction, protocol ownership, clinical-review process, and whether the deployment creates regulated medical-device obligations. | Review BAA coverage, transcript and symptom-data retention, AWS hosting, encryption, identity handling, email limitations, EHR/CRM integrations, and customer-controller responsibilities before launch. | Validate triage dispositions, emergency handling, endpoint fit, false reassurance, over-triage, and patient completion in the local service map and acuity mix. | Deploy with explicit care endpoints, emergency scripts, staff escalation queues, scheduling rules, marketing boundaries, and post-launch review of unexpected triage patterns. |
| Syllable Healthcare Agents | Treat as access and workflow automation unless an agent is configured for symptoms, clinical guidance, or autonomous EHR actions that require clinical-governance and regulatory review. | Verify BAA terms, Epic authorization scope, transcript retention, third-party model routing, speech vendor routing, logs, role access, and audit evidence for the exact channels and agents. | Run scripted and live-shadow tests for scheduling accuracy, patient verification, handoff quality, latency, tool failures, speech recognition, and unsafe or out-of-scope responses. | Limit each agent to named intents, approved tools, identity checks, escalation rules, and monitoring dashboards before expanding to additional access-center workflows. |
| Prenosis Sepsis ImmunoScore | Treat as prescription AI/ML-based medical-device software and match use to FDA De Novo DEN230036, including suspected sepsis context, adult ED or hospital patients, blood-culture workflow, and clinician-review requirements. | Review EHR, lab, biomarker, and cloud algorithm-suite data flows; PHI transfer; retention; access controls; security certifications; audit logs; and BAA or data-processing terms before production use. | Validate local performance against sepsis prevalence, laboratory workflows, demographics, comorbidities, SEP-1 objectives, false-positive burden, and missed-sepsis risk rather than relying on authorization alone. | Best governed through emergency medicine, hospital medicine, infectious disease, nursing, lab, quality, and informatics teams with clear escalation, override, monitoring, and downtime procedures. |
| Anumana ECG-AI | Match each deployment to the exact cleared algorithm and intended use, including K232699 for low ejection fraction and K252360 for pulmonary hypertension; do not generalize clearance across future or investigational cardiac conditions. | Review ECG, EHR, result-routing, audit-log, customer-support, and integration data flows; Anumana says the pulmonary hypertension algorithm runs within the health-system environment, but contract and architecture review still matter. | Evaluate local performance by ECG source, patient mix, prevalence, care setting, downstream echo or referral pathway, false-positive burden, and whether published sensitivity and specificity match the intended workflow. | Best governed as clinician-reviewed cardiac detection support with defined ECG-system integration, result display, referral criteria, cardiology escalation, monitoring, and patient communication rules. |
| Tempus | Separate molecular assays, companion-diagnostic claims, EHR assistants, imaging algorithms, trial matching, and care-pathway notifications because each workflow can carry different regulatory and clinical accountability. | Review whether data is handled under website privacy, notice-of-privacy-practices, customer contract, research agreement, or de-identified data program before connecting EHR, genomic, imaging, or real-world datasets. | Require product-level validation for the disease area, data type, model output, and care setting rather than relying on broad precision-medicine platform positioning. | Map how outputs enter tumor boards, EHR workflows, trial screening, imaging review, care-gap closure, or life-sciences analysis, and define who approves downstream actions. |
| SOPHiA GENETICS | Confirm the exact SOPHiA DDM module, Dx-mode status, IVDR claim, local lab validation path, and whether the workflow is diagnostic, research, or exploratory before clinical use. | Review data-protection flyers, hosting model, anonymization, sample control, cross-institution insight sharing, HIPAA/GDPR commitments, and the customer agreement for genomic or imaging data. | Validate the assay, scanner, sequencing, and module performance against the lab's specimen type, disease area, population, and local quality-management requirements. | Map sample preparation, sequencing or imaging, data upload, interpretation, LIMS/EHR transfer, clinician review, and exception handling before relying on outputs. |
| Guardant InfinityAI | Separate exploratory cohort analytics, biomarker discovery, testing-value analysis, and any patient-specific use because each can carry different clinical, regulatory, or submission expectations. | Review consent, de-identification, data-use agreements, partner access, longitudinal clinical-genomic linkage, and any customer-data upload before using oncology datasets. | Check data provenance, completeness, cohort definitions, molecular-pattern methods, external validation, and whether insights are hypotheses, real-world evidence, or clinically actionable findings. | Use with oncology, bioinformatics, regulatory, privacy, and commercial review paths before applying outputs to trials, testing strategy, or patient-care workflows. |
| ArteraAI Prostate | Verify the exact ArteraAI Prostate version and indication against FDA De Novo DEN240068, CLIA/CAP lab status, scanner compatibility, NCCN-referenced use, CE/IVDR status, and partner-specific implementations before clinical use. | Review the HIPAA notice, privacy policy, ordering workflow, lab data handling, de-identification, retention, report access, and payer or partner data flows because the test uses pathology images and clinical information. | Check validation cohorts, Phase 3 trial evidence, population representation, endpoint definitions, scanner or specimen constraints, and whether the report output supports the intended decision in the local tumor board workflow. | Use as a clinician-ordered precision-oncology input with urology, radiation oncology, pathology, and patient shared-decision review before treatment intensification, active surveillance, salvage therapy, or metastatic prostate workflows are changed. |
| Unlearn | Treat as clinical trial methodology and evidence-generation infrastructure that needs protocol, SAP, ethics, sponsor, and regulator review before affecting enrollment or analysis. | Review trial-participant data flows, baseline-variable scope, consent, de-identification, retention, transfers, automated-decision disclosures, and sponsor agreements. | Inspect disease-model validation, calibration, external generalizability, uncertainty intervals, bias testing, and whether assumptions match the endpoint and population. | Best used with biostatistical governance where digital-twin outputs are versioned, auditable, and reconciled with trial operations and regulatory commitments. |
| Owkin K Pro | Treat K Pro as biomedical research and drug-development support unless a deployment links outputs to patient-specific care or regulated-development decisions that need formal controls. | Confirm whether data enters Owkin K, a customer environment, or the patient-data network, then review GDPR, ISO, data-transfer, de-identification, and access-control terms. | Require visible source data, reproducible methods, statistical assumptions, uncertainty, and expert review for target, biomarker, subgroup, or report-generation claims. | Best used inside governed R&D workflows where domain scientists review generated analyses before they influence experiments, trial design, or translational strategy. |
| Caris Life Sciences | Review the selected assay, laboratory status, report language, AI signature, and molecular tumor board use separately instead of treating Caris as one uniform AI product. | Confirm patient consent, molecular-data handling, data-use permissions, portal access, retention, and whether research, biopharma, or clinical workflows have different terms. | Check the biomarker, signature, and treatment-association evidence for the cancer type and report context before using outputs in clinical recommendations. | Route AI insights through oncologist, molecular pathology, genetic counseling, payer, and tumor board review as appropriate for the test and patient context. |
| Flatiron Assist | Treat as high-governance oncology clinical decision support; verify how pathways, NCCN content, local preferences, biomarkers, and prior-authorization workflows affect clinical accountability. | Review EHR integration, user permissions, patient-data exchange, reporting exports, pathway analytics, and contractual PHI terms before enabling point-of-care use. | Validate guideline currency, custom pathway governance, biomarker fit, trial matching, concordance reporting, and denial impact against local oncology practice. | Best governed through oncology pathway committees, EHR build review, clinician override tracking, prior-authorization monitoring, and periodic pathway updates. |
| Truveta | Treat Truveta as research, analytics, and evidence infrastructure, not clinical decision software, unless a deployment changes patient care or supports a regulated submission that needs study-specific controls. | Review de-identification, data-use agreements, linked-data scope, trusted research environment controls, HITRUST/SOC/ISO materials, and whether any customer-provided data changes obligations. | Validate cohort definitions, code sets, source traces, assumptions, missingness, confounding, and reproducibility artifacts before using outputs for regulatory, clinical, or commercial decisions. | Best used with defined research protocols, analyst review, versioned methods, and governed export paths rather than ad hoc natural-language answers. |
| Deep 6 AI | Treat as research operations and trial-matching infrastructure; confirm IRB, recruitment, consent, and clinical-trial obligations before using matches for patient contact. | Review EHR data access, PHI handling, site agreements, role permissions, audit trails, data retention, and whether sponsor-facing workflows expose identifiable data. | Validate extraction accuracy against local charts, especially for nuanced inclusion and exclusion criteria, temporality, biomarkers, medications, and comorbidities. | Best used with study-team review loops where AI-ranked candidates are confirmed by trained staff before outreach, enrollment, or protocol decisions. |
| Dyania Health Synapsis | Treat as research operations, chart review, and evidence infrastructure unless a deployment directly changes patient care; confirm IRB, protocol, registry, and sponsor obligations before use. | Review BAA terms, EHR access, PHI handling, role permissions, audit trails, retention, and whether sponsor-facing workflows expose identifiable or re-identifiable records. | Validate extraction and matching accuracy against local charts, especially for nuanced criteria, dates, negation, biomarkers, medications, disease status, and missing data. | Best used with explicit human confirmation steps before trial outreach, registry submission, protocol decisions, or real-world evidence conclusions. |
| TriNetX | Treat as clinical research, feasibility, and real-world evidence infrastructure unless a deployment directly affects patient care; align use with protocol, IRB, sponsor, and regional research rules. | Review federation model, data rights, de-identification or pseudonymization, site-level patient re-identification workflow, audit logs, retention, and cross-border data controls. | Validate cohort counts, criteria logic, ontology mappings, missing-data assumptions, site performance signals, and diversity metrics against known local or sponsor trial data. | Best used as decision support for study teams, with documented human confirmation before protocol amendments, site selection, patient outreach, or RWE conclusions. |
| Medidata AI | Treat as regulated clinical research infrastructure; protocol changes, external controls, synthetic data, and trial-risk actions need statistical, clinical, sponsor, and regulatory review. | Review trial-data rights, RWD linkage, patient-level data handling, synthetic data controls, role permissions, auditability, retention, and trust documentation. | Validate recommendations against the study protocol, therapeutic area, geography, enrollment history, endpoint definitions, safety signals, and statistical analysis plan. | Best deployed inside formal clinical operations governance, with traceable human decisions before protocol optimization, site actions, data queries, or external comparator use. |
| ConcertAI | Treat as oncology RWE, trial, and analytics infrastructure unless a specific workflow is used in patient care or a regulated submission; align each use with protocol, sponsor, IRB, and regulatory expectations. | Review de-identification, data rights, oncology network agreements, biomarker data handling, customer-data uploads, role access, retention, and whether sponsor-facing outputs expose site or patient-level information. | Validate cohort definitions, real-world data completeness, biomarker capture, model assumptions, source traceability, and study reproducibility before relying on outputs for evidence or trial decisions. | Best used with oncology research, biostatistics, trial operations, privacy, and clinical governance so AI-generated insights are reviewed before trial, commercial, or quality programs change. |
| Aetion Evidence Platform | Treat as evidence-generation infrastructure; regulatory, payer, safety, or HTA use needs protocol, data, methods, versioning, and review controls matched to the decision. | Review data-source agreements, cloud deployment, de-identification, synthetic data generation, user permissions, audit exports, and whether linked or customer-provided data changes obligations. | Check study design, cohort logic, outcome definitions, confounding control, sensitivity analyses, reproducibility, and whether AI-assisted steps are transparent enough for review. | Best used by epidemiology, HEOR, safety, regulatory, and analytics teams with reusable study components and explicit signoff before evidence leaves the research workflow. |
| nference nSights | Treat as research and evidence infrastructure unless outputs are linked to patient-specific care, diagnostics, or regulated submissions that require formal controls. | Review de-identification, federated or licensed-data access, institution data rights, modality add-ons, exports, retention, and user permissions before using sensitive cohorts. | Validate cohort logic, source-data completeness, AI curation methods, modality coverage, missingness, and reproducibility for the intended drug, diagnostic, or research question. | Best used with clinical research, informatics, biostatistics, privacy, and domain-science review before insights feed experiments, publications, models, or development programs. |
| Product | Workflow | Risk | Best fit | First verification check |
|---|---|---|---|---|
| OpenEvidence Clinical evidence and questions |
Evidence-backed clinical questions and medical literature synthesis | High | Clinicians who need fast answers grounded in medical literature and source partnerships. | Whether your user type and region are eligible. |
| ClinicalKey AI Clinical evidence and questions |
Generative AI clinical question answering grounded in licensed medical reference content | High | Health systems and clinicians that want a governed alternative to general-purpose AI for point-of-care clinical reference questions. | Whether your institution's license covers the intended user group and country. |
| UpToDate Expert AI Clinical evidence and questions |
Conversational clinical question answering grounded in UpToDate content, assumptions, source links, and clinician review | High | Clinicians and health systems that want AI-assisted clinical reference answers inside an established UpToDate evidence workflow. | Whether Expert AI is available for your country, subscription tier, professional role, and enterprise account. |
| Dyna AI Clinical evidence and questions |
AI-assisted evidence retrieval and clinical question answering inside EBSCO clinical decision-support content | High | Clinical teams that already rely on EBSCO evidence products and want AI-assisted retrieval with direct source links and clinician control. | Which host product is licensed: DynaMed, DynaMedex, Dynamic Health, or Dyna AI Mode. |
| Glass Health Clinical evidence and questions |
Differential diagnosis drafts, assessment and plan drafts, and clinical decision support | High | Clinicians looking for guided clinical reasoning drafts with clinician review. | Evidence sources and guideline maintenance process. |
| Atropos Health Clinical evidence and questions |
Real-world evidence generation, clinical evidence agents, and EHR-connected evidence support | Medium to high | Organizations that need source-backed real-world evidence for clinical questions, policy, research, or precision-medicine workflows. | Which data network or local data source will answer the clinical question. |
| Doximity Ask Clinical evidence and questions |
HIPAA-compliant clinician assistant for clinical questions, patient education, chart note templates, translation, and document drafting | Medium to high | Clinicians already using Doximity who want a PHI-capable assistant for first-draft clinical reference, correspondence, education, and workflow writing. | Whether your clinician role, country, and Doximity verification status are eligible. |
| AvoMD Clinical evidence and questions |
AI-assisted clinical decision support, local guideline workflows, medical calculators, pathways, and clinician-facing care algorithms | Medium to high | Organizations that want locally governed clinical pathways and calculators embedded into clinician workflows with reviewable source logic. | Which pathway, calculator, Ask Avo workflow, or EHR integration is being deployed. |
| Causaly Clinical evidence and questions |
Agentic biomedical research, evidence retrieval, knowledge-graph exploration, target assessment, and scientific workflow automation | Medium to high | Teams that need traceable biomedical evidence, internal-data research workflows, target or indication assessment, and repeatable scientific decision support. | Which Causaly module is in scope: Agentic Research, Discover, Bio Graph, Pipeline Graph, or private-data workflows. |
| Oracle Health Clinical AI Agent Clinical documentation and scribes |
EHR-connected clinical AI agent for chart review, documentation, scheduling, patient access, care coordination, and operational workflows | Medium to high | Oracle Health customers evaluating embedded AI workflows that combine chart review, documentation, patient access, and administrative coordination. | Which agent or module is live in your licensed environment versus planned: chart review, documentation, scheduling, referrals, patient self-service, or financial transparency. |
| Aidoc Medical imaging and radiology |
Radiology triage, scan analysis, care-team activation, and enterprise AI orchestration | High | Health systems deploying multiple imaging AI algorithms and governance workflows. | FDA-cleared algorithms that match your exact modality and use case. |
| Viz.ai Medical imaging and radiology |
AI-powered care coordination around suspected disease detection and specialist activation | High | Teams that need rapid disease detection alerts and coordinated response pathways. | Which algorithms are FDA-cleared for your use case. |
Tools for clinicians, researchers, and students asking medical questions, searching literature, or building evidence-backed summaries.
Ambient scribes and documentation assistants that capture encounters, draft notes, support coding, or prepare visit context.
AI for radiology, cardiology imaging, pathology imaging, triage, detection, reporting, and care coordination around images.
AI-enabled pathology viewers, algorithms, and diagnostic support for whole-slide images and lab workflows.
AI for clinical insights, coding, revenue cycle, report drafting, and operational workflows that affect care delivery or reimbursement.
Symptom checkers, intake tools, patient navigation, post-discharge outreach, and healthcare-specific AI agents.
AI platforms for genomics, oncology, real-world data, multimodal clinical data, and personalized medicine workflows.
Tools for clinicians, researchers, and students asking medical questions, searching literature, or building evidence-backed summaries.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| OpenEvidence | Evidence-backed clinical questions and medical literature synthesis | Whether your user type and region are eligible. | 3 official sources |
| ClinicalKey AI | Generative AI clinical question answering grounded in licensed medical reference content | Whether your institution's license covers the intended user group and country. | 4 official sources |
| UpToDate Expert AI | Conversational clinical question answering grounded in UpToDate content, assumptions, source links, and clinician review | Whether Expert AI is available for your country, subscription tier, professional role, and enterprise account. | 3 official sources |
| Dyna AI | AI-assisted evidence retrieval and clinical question answering inside EBSCO clinical decision-support content | Which host product is licensed: DynaMed, DynaMedex, Dynamic Health, or Dyna AI Mode. | 4 official sources |
| Glass Health | Differential diagnosis drafts, assessment and plan drafts, and clinical decision support | Evidence sources and guideline maintenance process. | 2 official sources |
| Consensus | Medical research discovery, study snapshots, and evidence-backed answers | Which databases and journals are searched. | 2 official sources |
| Elicit | Systematic-review search, screening, extraction, and research-backed reports | Database coverage and deduplication process. | 3 official sources |
| Scite | Citation-context search, paper evaluation, and AI research synthesis | Citation coverage for your specialty. | 2 official sources |
| Atropos Health | Real-world evidence generation, clinical evidence agents, and EHR-connected evidence support | Which data network or local data source will answer the clinical question. | 4 official sources |
| Doximity Ask | HIPAA-compliant clinician assistant for clinical questions, patient education, chart note templates, translation, and document drafting | Whether your clinician role, country, and Doximity verification status are eligible. | 3 official sources |
| AvoMD | AI-assisted clinical decision support, local guideline workflows, medical calculators, pathways, and clinician-facing care algorithms | Which pathway, calculator, Ask Avo workflow, or EHR integration is being deployed. | 4 official sources |
| Causaly | Agentic biomedical research, evidence retrieval, knowledge-graph exploration, target assessment, and scientific workflow automation | Which Causaly module is in scope: Agentic Research, Discover, Bio Graph, Pipeline Graph, or private-data workflows. | 5 official sources |
Ambient scribes and documentation assistants that capture encounters, draft notes, support coding, or prepare visit context.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Abridge | Ambient clinical documentation and clinician-reviewed note drafts | BAA, audio, transcript, and training-data terms. | 3 official sources |
| Ambience Healthcare | Real-time clinical documentation, coding, and CDI support | Specialty coverage for your service lines. | 3 official sources |
| Nuance DAX Copilot | Ambient clinical documentation automation for EHR workflows | EHR support for your system. | 2 official sources |
| Microsoft Dragon Copilot | Role-based clinical AI assistant for documentation, information surfacing, reporting, coding suggestions, and workflow automation | Which role experience is in scope: physician, nurse, radiologist, or developer-kit integration. | 3 official sources |
| Oracle Health Clinical AI Agent | EHR-connected clinical AI agent for chart review, documentation, scheduling, patient access, care coordination, and operational workflows | Which agent or module is live in your licensed environment versus planned: chart review, documentation, scheduling, referrals, patient self-service, or financial transparency. | 3 official sources |
| AWS HealthScribe | API-based ambient transcription, clinical note drafting, and transcript-linked evidence mapping | Whether your workflow uses HealthScribe batch jobs, streaming, Amazon Connect Health Ambient, or a partner application built on the API. | 3 official sources |
| Suki | Ambient documentation, coding support, clinical reasoning, and Q&A | Supported EHRs and specialty settings. | 2 official sources |
| Nabla | AI scribe, live transcript, note drafts, and EHR-connected documentation | No-audio-storage default and data-training terms. | 3 official sources |
| DeepScribe | Ambient scribe, pre-charting, coding, and context-aware documentation | Specialty-specific note accuracy. | 4 official sources |
| Freed | AI scribe for SOAP notes and visit documentation | BAA and HIPAA terms for your workflow. | 2 official sources |
| Heidi Health | AI medical scribe, clinical note generation, evidence search, and patient communications support | Which Heidi product is in scope: Scribe, Evidence, Comms, or a combined workflow. | 3 official sources |
| ModMed Scribe | Ambient clinical documentation, structured note suggestions, billing code suggestions, and downstream EHR workflow automation | Whether your specialty and EMA workflow are supported. | 3 official sources |
| Augmedix | Ambient medical documentation, live note support, after-visit documentation, and EHR-connected clinical workflow support | Which product is in scope: Augmedix Go, Live, Assist, or another documentation workflow. | 4 official sources |
| Commure Ambient AI | Ambient AI documentation, clinician assistant workflows, care cues, macros, coding support, and EHR-connected clinical operations | Which Commure tier or workflow is in scope: Ambient AI, Ambient AI Scribing, AI Assistant, CareCues, Macros, autonomous coding, or a broader RCM integration. | 4 official sources |
| Tali AI | AI ambient scribe, medical dictation, note generation, and clinician-reviewed documentation | Whether the U.S., Canadian, or enterprise deployment path matches your privacy, data residency, and contracting requirements. | 5 official sources |
| Twofold Health | AI medical scribe for structured clinical notes, therapy notes, and encounter documentation | Whether your specialty templates, note formats, and therapy documentation needs are supported. | 3 official sources |
| TORTUS | AI medical scribe for consultation notes, transcripts, codes, and NHS-aligned documentation workflows | Whether the product, site, and workflow are covered by current NHS DTAC, clinical-safety, cyber-security, and data-protection approvals. | 3 official sources |
AI for radiology, cardiology imaging, pathology imaging, triage, detection, reporting, and care coordination around images.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Aidoc | Radiology triage, scan analysis, care-team activation, and enterprise AI orchestration | FDA-cleared algorithms that match your exact modality and use case. | 4 official sources |
| Viz.ai | AI-powered care coordination around suspected disease detection and specialist activation | Which algorithms are FDA-cleared for your use case. | 4 official sources |
| Ferrum Health | Clinical AI governance suite for deploying, monitoring, validating, and managing imaging and other clinical AI models across existing infrastructure | Which models, service lines, PACS/RIS/EHR connections, deployment fabric, and governance modules are included in the scope. | 4 official sources |
| Blackford Platform | Enterprise radiology AI orchestration, relevancy routing, curated marketplace access, deployment monitoring, and AI application management | Which Blackford Platform functions and marketplace applications are in scope. | 4 official sources |
| Brainomix 360 Stroke | AI-enabled CT, CTA, MRI, and mobile stroke workflow support for suspected acute stroke assessment and transfer decisions | Which Brainomix 360 Stroke modules are in scope, such as e-ASPECTS, e-CTA, Triage Stroke, core-volume, e-MRI, or mobile notifications. | 5 official sources |
| Qure.ai | Chest X-ray, CT, lung cancer, tuberculosis, and stroke imaging workflows | Product-specific clearance and local regulatory status. | 4 official sources |
| Rad AI | Radiology report drafting, impression generation, and reporting workflow automation | Whether the product handles your modalities and templates. | 3 official sources |
| Cleerly | AI-enabled coronary CT angiography and plaque analysis | Regulatory status and intended use in your country. | 5 official sources |
| Elucid PlaqueIQ | AI-enabled coronary CTA plaque composition and lesion-level plaque analysis | FDA 510(k) indication, software version, and whether the intended coronary CTA workflow matches the clearance. | 5 official sources |
| LumineticsCore | Autonomous AI diabetic retinopathy detection from retinal images at the point of care | FDA De Novo authorization, indications for use, contraindications, and exact eligible patient population. | 4 official sources |
| Eyenuk EyeArt | Autonomous AI diabetic retinopathy screening from color retinal fundus images | FDA 510(k) record, current EyeArt version, supported camera models, intended-use language, and eligible patient population. | 5 official sources |
| RapidAI | AI-powered imaging triage, quantification, disease detection, and care-team workflow support | Which RapidAI module is in scope and whether its clearance matches the exact modality, anatomy, and intended use. | 6 official sources |
| Heartflow | AI-powered coronary CTA analysis, FFRCT physiology analysis, plaque analysis, and coronary roadmap workflows | Which Heartflow product is being used: FFRCT, Plaque Analysis, Roadmap Analysis, or another module. | 6 official sources |
| Ultromics EchoGo | AI-assisted echocardiography analysis for HFpEF detection support and cardiac workflow reporting | Whether the selected EchoGo Heart Failure version and 510(k) clearance match the intended echocardiography workflow. | 4 official sources |
| Gleamer BoneView | AI-assisted fracture detection and trauma X-ray second-reader workflow support | FDA K222176 intended use, covered anatomy, patient age limits, warnings, and region-specific availability. | 4 official sources |
| iCAD ProFound AI | AI-assisted breast cancer detection, mammography case scoring, density assessment, and short-term risk workflow support | Which module is in scope: ProFound Detection, ProFound AI for DBT, density assessment, risk scoring, or another breast-health workflow. | 4 official sources |
| ScreenPoint Transpara | AI-assisted breast cancer detection, density assessment, temporal comparison, and mammography workflow support | Which Transpara module is in scope: Detection, Density, Temporal Comparison, or another breast AI workflow. | 3 official sources |
| Koios DS Breast | AI-assisted risk assessment and computer-aided diagnosis support for breast ultrasound lesions | Whether Koios DS Breast, Koios DS, or another module/version matches the intended breast ultrasound workflow. | 4 official sources |
| Subtle Medical | AI-powered MRI and PET image enhancement, denoising, acceleration, and synthetic imaging workflow support | Which tool is in scope: SubtleMR, SubtlePET, SubtleHD, SubtleSYNTH, SubtleALIGN, or an integrated partner workflow. | 6 official sources |
| Lunit | AI cancer screening, breast imaging, chest X-ray, precision oncology, and pathology biomarker workflows | Which module is in scope: INSIGHT MMG, INSIGHT DBT, INSIGHT CXR, SCOPE IO, SCOPE IHC, SCOPE GP, or a Volpara-derived workflow. | 3 official sources |
| annalise.ai | Chest X-ray, non-contrast head CT, radiology triage, decision support, worklist prioritization, and draft reporting support | Which product is being evaluated: Annalise Enterprise CXR, Enterprise CTB, Annalise Triage, Reporting, or a regional Harrison.ai-branded workflow. | 4 official sources |
| CureMetrix | AI-assisted mammography worklist triage and breast-screening workflow prioritization | Whether the exact CureMetrix module is cmTriage, cmAssist, or another breast-imaging workflow. | 3 official sources |
| GE HealthCare Caption AI | AI-guided cardiac ultrasound acquisition and automated ejection-fraction support on compatible GE HealthCare ultrasound systems | Which GE ultrasound system, Caption Guidance feature, or Caption Interpretation AutoEF workflow is in scope. | 4 official sources |
| Butterfly iQ3 | Handheld point-of-care ultrasound with AI-enabled workflow software and gestational-age AI tooling in eligible settings | Which probe generation, software plan, AI feature, and clinical workflow is being deployed. | 4 official sources |
| Pearl Second Opinion | AI-assisted dental radiograph review, pathology detection, patient education, and 2D or 3D dental image analysis | Which Pearl module is in scope: Second Opinion 2D, Second Opinion 3D, bone-level features, claims review, or another workflow. | 5 official sources |
| Overjet | FDA-cleared dental X-ray analysis, caries support, bone-level measurement, image enhancement, and dental workflow automation | Which product is being used: Vision AI, Dental Assist, Caries Assist, IRIS, image enhancement, payer review, voice, or insurance verification. | 6 official sources |
| VideaAI | Dental X-ray AI for clinical assist, patient education, caries and periodontal findings, and practice workflow insights | Which Videa product is in scope: Clinical Assist, Patient View, Daily Dashboard, Voice Notes, Clean Claims, AutoVerify, or another platform module. | 4 official sources |
AI-enabled pathology viewers, algorithms, and diagnostic support for whole-slide images and lab workflows.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Paige | AI-assisted digital pathology and prostate cancer detection support | FDA authorization and exact intended use for the selected product. | 2 official sources |
| PathAI | Digital pathology image management, AI algorithms, quality control, and lab workflow | Which AISight version and algorithms are diagnostic versus research use only. | 4 official sources |
| Ibex Medical Analytics | AI-powered pathology workflows for cancer detection, grading, biomarker support, and structured reporting | Which Ibex module, tissue type, and workflow is being evaluated. | 6 official sources |
| Proscia | Digital pathology image management, AI application deployment, model development, and lab workflow orchestration | Whether Concentriq AP, Dx, LS, or another deployment model fits the lab setting. | 6 official sources |
| Aiforia | AI-assisted digital pathology suites for cancer diagnostics, quantitative image analysis, and case-level pathology reporting | Which Aiforia clinical suite and AI models match the tissue, stain, and diagnostic workflow. | 6 official sources |
| Mindpeak | AI-assisted tissue image analysis for breast biomarkers, PD-L1, HER2, tumor detection, and pathology workflow support | Which Mindpeak suite or module is in scope: breast IHC, PD-L1, HER2, prostate, onychomycosis, lymphocyte quantification, peakDissect, or a biopharma workflow. | 4 official sources |
| Aignostics | Research-use digital pathology foundation-model analysis for H&E tumor microenvironment profiling and quantitative spatial metrics | Research-use-only status and whether any workflow is explicitly excluded from diagnostic procedures. | 3 official sources |
| Lumea | Integrated digital pathology workflow with tissue-handling tools, FDA-cleared viewer, LIS-enabled case management, AI ecosystem access, and molecular test ordering | Which Lumea component is in scope: Viewer+, BxLink, tissue-handling tools, specialty workflow, AI marketplace, or molecular ordering. | 5 official sources |
| Visiopharm | AI-driven precision pathology image analysis, biomarker scoring, diagnostic decision support APPs, research analysis, and workflow integrations | Which Visiopharm platform or APP is in scope: diagnostic decision support, Discovery, Phenoplex, Qualitopix, or a partner integration. | 5 official sources |
| Tribun Health | CaloPix image management, digital slide viewing, AI app integration, telepathology, archive workflow, and pathology platform modernization | Which module is being purchased: CaloPix, CaloPix Archive, AI Apps, TeleSlide, MacroCam, or a partner integration. | 4 official sources |
| DoMore Diagnostics Histotype Px Colorectal | AI-powered digital biomarker for stage II and stage III colorectal cancer outcome prediction from routine H&E histology slides | Whether Histotype Px Colorectal is cleared or CE-marked for the intended country, cancer stage, specimen, scanner, and diagnostic or research workflow. | 4 official sources |
AI for clinical insights, coding, revenue cycle, report drafting, and operational workflows that affect care delivery or reimbursement.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Regard | Clinical insights from EHR data, pre-visit documentation, and missed-condition surfacing | EHR integration and data mapping. | 3 official sources |
| Bayesian Health | Real-time EHR-based clinical intelligence, patient risk monitoring, early warning, care-pathway activation, and performance reporting | Which Bayesian module or clinical pathway is in scope and whether the intended use is alerting, risk stratification, care coordination, reporting, or decision support. | 4 official sources |
| Fathom | Autonomous medical coding and coding automation | Automation rate and accuracy by specialty and claim type. | 3 official sources |
| CodaMetrix | Contextual coding automation and medical coding performance improvement | Service line coverage and payer-rule support. | 3 official sources |
| SmarterDx | Clinical AI for revenue integrity, prebill diagnosis review, charge validation, denials appeals, and note-level revenue intelligence | Which SmarterDx module is in scope: SmarterPrebill, SmarterDenials, SmarterNotes, SmarterCharges, or a combined Smarter Technologies workflow. | 4 official sources |
| Waystar AltitudeAI | AI-powered healthcare payment and revenue cycle automation across financial clearance, clinical integrity, claims, denials, and reporting | Which Waystar module is in scope: financial clearance, clinical integrity and revenue capture, claim management, denial recovery, payment management, or analytics. | 3 official sources |
| Tennr | Agentic patient-flow automation for referrals, orders, document intake, eligibility, prior authorization, triage, and outreach | Which workflow is in scope: referral intake, order processing, eligibility, prior authorization, intelligent triage, communications coordination, or autopilot completion. | 4 official sources |
| AKASA | Generative AI for revenue cycle, coding optimization, CDI, authorization status, and claim status workflows | Which revenue cycle workflow is in scope: coding, CDI, auth status, claim status, or research. | 4 official sources |
| Notable | AI-powered healthcare automation for patient access, intake, authorization, scheduling, and administrative workflows | Which workflows are automated and which require staff review. | 4 official sources |
| Qventus | AI-powered healthcare operations automation, inpatient capacity, surgical growth, perioperative coordination, and operational assistants | Which operational workflow is in scope: surgical growth, pre-admission testing, perioperative coordination, inpatient capacity, or assistant-led follow-up. | 3 official sources |
| LeanTaaS iQueue | AI and machine-learning capacity management for operating rooms, infusion centers, inpatient flow, scheduling, and hospital operations | Which iQueue module is in scope: Operating Rooms, Infusion Centers, Inpatient Flow, or Autopilot-enabled operational workflows. | 5 official sources |
| Iodine AwareCDI | AI-powered clinical documentation integrity, mid-revenue-cycle review, condition capture, coding support, and CDI prioritization | Which Iodine workflow is in scope: AwareCDI, Concurrent, Retrospect, pre-bill, post-bill, or coding support. | 3 official sources |
| Cohere Health | AI-powered prior authorization, utilization management, payment integrity, clinical policy review, and payer-provider collaboration | Which workflow is in scope: prior authorization, delegated utilization, API-based CMS-0057 compliance, payment integrity, appeals, or clinical policy review. | 4 official sources |
| Xsolis Dragonfly | AI-powered utilization management, medical-necessity review, concurrent authorization, discharge planning, denial prevention, and payer-provider collaboration | Whether the workflow is admission review, continued stay, concurrent authorization, discharge planning, appeal support, payment integrity, or payer-provider data sharing. | 5 official sources |
Open the clinical operations and revenue cycle category page
Symptom checkers, intake tools, patient navigation, post-discharge outreach, and healthcare-specific AI agents.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Hippocratic AI | Generative AI healthcare agents for outreach, patient engagement, and operational tasks | Agent scope and forbidden tasks. | 3 official sources |
| Infermedica | Symptom checking, preliminary symptom analysis, patient triage, and navigation APIs | Triage levels and emergency scripts. | 3 official sources |
| Ubie | AI symptom checking, possible-cause reports, patient education, and care-seeking guidance | Whether the intended workflow is consumer self-checking, provider front door, patient education, or partner integration. | 4 official sources |
| Hyro | Healthcare AI agents for call center automation, scheduling, patient support, and conversational intelligence | Which channels and intents the agent is allowed to handle. | 3 official sources |
| Infinitus | AI agents for healthcare calls, benefit verification, prior authorization follow-up, patient onboarding, affordability, adherence, and provider or payor outreach | Which agent type is in scope: patient navigator, benefit verification, prior authorization, formulary exception, appeals, bridge eligibility, insurance discovery, provider education, missing information, or adherence check-ins. | 4 official sources |
| Artera Harmony | AI-enabled patient communications, messaging orchestration, self-scheduling, intake, billing outreach, forms, and voice or text agents | Which Artera workflow is in scope: Harmony orchestration, AI agents, self-scheduling, intake, forms, billing, call-to-text, staff co-pilot, or sentiment analysis. | 4 official sources |
| Fabric | Care access platform for intake, triage, routing, virtual care, scheduling, and conversational AI | Whether the workflow is administrative routing, symptom collection, triage, or virtual care delivery. | 3 official sources |
| Corti | Healthcare AI agent framework, speech-to-text, coding support, documentation generation, and workflow-specific clinical agents | Which workflow is being built: speech-to-text, coding, documentation, prior authorization, guideline support, care coordination, or patient access. | 3 official sources |
| Sully.ai | AI healthcare agents for documentation, receptionist workflows, triage roles, coding, EHR integration, and developer-facing clinical-note APIs | Which agent is in scope: scribe, receptionist, triage nurse, coder, pharmacist, interpreter, or custom API workflow. | 2 official sources |
| Memora Health | AI-enabled care journeys, two-way texting, symptom management, patient-reported outcomes, check-ins, education, and escalation to care teams | Which program is in scope: remote patient monitoring, symptom management, patient education, automated check-ins, patient-reported outcomes, adherence, VBC reporting, or care-team collaboration. | 4 official sources |
| Ada Health | AI-powered symptom assessment, care navigation, digital triage, clinical handover, and population insights | Whether the workflow uses consumer Ada, Ada Assess, care navigation, clinical handover, or partner-specific modules. | 4 official sources |
| Mediktor | AI-based symptom assessment, digital triage, care routing, patient assistance, and LLM-enhanced medical-agent workflows | Which Mediktor workflow is in scope: symptom checker, business platform, AI Medical Agent, telemedicine, insurer, provider, public-health, or pharma use case. | 5 official sources |
| Luma Health Navigator | AI-powered patient self-service, appointment changes, refill requests, voice-to-SMS continuity, multilingual access, and operational AI workflows | Which Luma workflow is in scope: Navigator AI concierge, Spark, Fax Transform, scheduling, waitlist, referrals, intake, payments, eligibility, reminders, or operational AI orchestration. | 5 official sources |
| Clearstep Smart Care Routing | AI chat and voice triage, symptom assessment, care navigation, scheduling handoff, and white-labeled digital front door routing | Whether the deployment uses virtual triage, AI chat, AI voice, API integration, authenticated portal workflows, scheduling, or CRM/EHR writeback. | 5 official sources |
| Syllable Healthcare Agents | AI agents for appointment scheduling, patient verification, waitlist management, referral processing, call routing, outbound reminders, and EHR-connected patient workflows | Which agent is in scope: healthcare receptionist, appointment scheduling, Epic scheduling, patient verification, waitlist, referral processing, outbound reminder, call routing, or medical-records outreach. | 5 official sources |
AI platforms for genomics, oncology, real-world data, multimodal clinical data, and personalized medicine workflows.
| Product | Primary use case | First verification check | Official sources |
|---|---|---|---|
| Prenosis Sepsis ImmunoScore | FDA-authorized AI diagnostic and predictive sepsis risk assessment using EHR, vital-sign, demographic, laboratory, and biomarker inputs | FDA De Novo DEN230036 intended use, patient eligibility, blood-culture-order requirement, 24-hour risk window, and prescription-use limits. | 4 official sources |
| Anumana ECG-AI | FDA-cleared ECG-AI algorithms for identifying cardiovascular risk signals from standard 12-lead ECG workflows | Which ECG-AI algorithm is in scope: low ejection fraction, pulmonary hypertension, cardiac amyloidosis, or another pipeline module. | 6 official sources |
| Tempus | AI-enabled precision medicine, multimodal data, diagnostics, and clinical trial support | Which Tempus product is in scope: One, Hub, Now, Lens, Pixel, Next Pathways, Next Trials, assays, or algos. | 5 official sources |
| SOPHiA GENETICS | AI-powered genomic, radiomic, and multimodal data analysis through the SOPHiA DDM platform | Whether the selected module is diagnostic, research, or local-validation use. | 3 official sources |
| Guardant InfinityAI | AI-enabled precision oncology data exploration, cohort analysis, molecular pattern discovery, and real-world evidence workflows | Which InfinityAI module, data library, or Guardant product feature is being evaluated. | 3 official sources |
| ArteraAI Prostate | AI-enabled digital pathology and clinical-data test for prostate cancer prognosis, therapy-benefit prediction, and treatment-intensity personalization | Whether the patient population matches the localized, non-metastatic, post-radical-prostatectomy, or metastatic hormone-sensitive prostate workflow being considered. | 5 official sources |
| Unlearn | AI-generated digital twins for clinical trial design, control-outcome forecasting, synthetic control comparisons, and statistical power planning | Which disease-specific Digital Twin Generator and study design are in scope. | 4 official sources |
| Owkin K Pro | Agentic AI for biomedical research, multimodal patient data analysis, target prioritization, biomarker validation, and drug-development decisions | Which datasets, AI skills, and biomedical tasks are available for the research question. | 3 official sources |
| Caris Life Sciences | AI-enabled molecular profiling, precision oncology insights, and tumor board reporting | Which test, report, or AI insight is being used and its exact clinical role. | 3 official sources |
| Flatiron Assist | EHR-integrated oncology clinical decision support, treatment pathways, biomarkers, trials, and prior authorization support | Which cancers, regimens, biomarkers, pathways, and clinical-trial workflows are supported. | 2 official sources |
| Truveta | AI-supported real-world data analytics, cohort building, regulatory-grade evidence generation, and natural-language research assistance | Which Truveta product is in scope: Data, Studio, Intelligence, Evidence, Tru, or Truveta Language Model-supported workflows. | 6 official sources |
| Deep 6 AI | AI-supported cohort discovery, clinical trial matching, protocol feasibility, patient identification, and real-world data extraction | Which workflow is in scope: cohort discovery, site feasibility, patient matching, chart abstraction, sponsor search, or network analytics. | 4 official sources |
| Dyania Health Synapsis | AI-assisted chart review, clinical trial screening, protocol matching, registry abstraction, and real-world data extraction from medical records | Which Synapsis workflow is in scope: trial screening, protocol feasibility, registry abstraction, chart review, or real-world evidence extraction. | 4 official sources |
| TriNetX | Real-world data network, AI-supported cohort discovery, protocol feasibility, site identification, and clinical trial recruitment planning | Which TriNetX module, dataset, geography, and trial workflow are in scope: feasibility, protocol design, site identification, recruitment planning, or RWE. | 4 official sources |
| Medidata AI | AI-supported clinical trial planning, protocol optimization, trial risk monitoring, data quality workflows, synthetic control arms, and integrated evidence | Which Medidata AI capability is in scope: Dot, protocol optimization, study feasibility, integrated evidence, synthetic control arm, data management, or operational monitoring. | 4 official sources |
| ConcertAI | Oncology-focused real-world data, generative and predictive AI, trial feasibility, trial screening, commercial insights, and care-quality analytics | Which ConcertAI product is in scope: PrecisionExplorer, PrecisionTRIALS, PrecisionGTM, Precision360, CancerLinQ, or a trial operations workflow. | 3 official sources |
| Aetion Evidence Platform | Real-world evidence generation, data preparation, cohort definition, causal analytics, regulatory-grade study workflows, and AI-assisted variable or subgroup work | Which Aetion product is being used: Evidence Platform, Discover, Activate, Substantiate, Generate, Science and Research services, or AetionAI-supported workflows. | 4 official sources |
| nference nSights | AI-assisted multimodal real-world data exploration, cohort analysis, clinical research insights, drug development support, and predictive model development | Which nSights application, dataset, modality, institution source, or analytics tier is available for the research question. | 4 official sources |
| Product | Category | Risk | Use case | Official sources | Source-backed profile |
|---|---|---|---|---|---|
| OpenEvidence | Clinical evidence and questions | High | Evidence-backed clinical questions and medical literature synthesis | 3 official sources | Review profile |
| ClinicalKey AI | Clinical evidence and questions | High | Generative AI clinical question answering grounded in licensed medical reference content | 4 official sources | Review profile |
| UpToDate Expert AI | Clinical evidence and questions | High | Conversational clinical question answering grounded in UpToDate content, assumptions, source links, and clinician review | 3 official sources | Review profile |
| Dyna AI | Clinical evidence and questions | High | AI-assisted evidence retrieval and clinical question answering inside EBSCO clinical decision-support content | 4 official sources | Review profile |
| Glass Health | Clinical evidence and questions | High | Differential diagnosis drafts, assessment and plan drafts, and clinical decision support | 2 official sources | Review profile |
| Consensus | Clinical evidence and questions | Medium | Medical research discovery, study snapshots, and evidence-backed answers | 2 official sources | Review profile |
| Elicit | Clinical evidence and questions | Medium | Systematic-review search, screening, extraction, and research-backed reports | 3 official sources | Review profile |
| Scite | Clinical evidence and questions | Medium | Citation-context search, paper evaluation, and AI research synthesis | 2 official sources | Review profile |
| Atropos Health | Clinical evidence and questions | Medium to high | Real-world evidence generation, clinical evidence agents, and EHR-connected evidence support | 4 official sources | Review profile |
| Doximity Ask | Clinical evidence and questions | Medium to high | HIPAA-compliant clinician assistant for clinical questions, patient education, chart note templates, translation, and document drafting | 3 official sources | Review profile |
| AvoMD | Clinical evidence and questions | Medium to high | AI-assisted clinical decision support, local guideline workflows, medical calculators, pathways, and clinician-facing care algorithms | 4 official sources | Review profile |
| Causaly | Clinical evidence and questions | Medium to high | Agentic biomedical research, evidence retrieval, knowledge-graph exploration, target assessment, and scientific workflow automation | 5 official sources | Review profile |
| Abridge | Clinical documentation and scribes | Lower to medium | Ambient clinical documentation and clinician-reviewed note drafts | 3 official sources | Review profile |
| Ambience Healthcare | Clinical documentation and scribes | Lower to medium | Real-time clinical documentation, coding, and CDI support | 3 official sources | Review profile |
| Nuance DAX Copilot | Clinical documentation and scribes | Lower to medium | Ambient clinical documentation automation for EHR workflows | 2 official sources | Review profile |
| Microsoft Dragon Copilot | Clinical documentation and scribes | Lower to medium | Role-based clinical AI assistant for documentation, information surfacing, reporting, coding suggestions, and workflow automation | 3 official sources | Review profile |
| Oracle Health Clinical AI Agent | Clinical documentation and scribes | Medium to high | EHR-connected clinical AI agent for chart review, documentation, scheduling, patient access, care coordination, and operational workflows | 3 official sources | Review profile |
| AWS HealthScribe | Clinical documentation and scribes | Lower to medium | API-based ambient transcription, clinical note drafting, and transcript-linked evidence mapping | 3 official sources | Review profile |
| Suki | Clinical documentation and scribes | Lower to medium | Ambient documentation, coding support, clinical reasoning, and Q&A | 2 official sources | Review profile |
| Nabla | Clinical documentation and scribes | Lower to medium | AI scribe, live transcript, note drafts, and EHR-connected documentation | 3 official sources | Review profile |
| DeepScribe | Clinical documentation and scribes | Lower to medium | Ambient scribe, pre-charting, coding, and context-aware documentation | 4 official sources | Review profile |
| Freed | Clinical documentation and scribes | Lower to medium | AI scribe for SOAP notes and visit documentation | 2 official sources | Review profile |
| Heidi Health | Clinical documentation and scribes | Lower to medium | AI medical scribe, clinical note generation, evidence search, and patient communications support | 3 official sources | Review profile |
| ModMed Scribe | Clinical documentation and scribes | Lower to medium | Ambient clinical documentation, structured note suggestions, billing code suggestions, and downstream EHR workflow automation | 3 official sources | Review profile |
| Augmedix | Clinical documentation and scribes | Lower to medium | Ambient medical documentation, live note support, after-visit documentation, and EHR-connected clinical workflow support | 4 official sources | Review profile |
| Commure Ambient AI | Clinical documentation and scribes | Lower to medium | Ambient AI documentation, clinician assistant workflows, care cues, macros, coding support, and EHR-connected clinical operations | 4 official sources | Review profile |
| Tali AI | Clinical documentation and scribes | Lower to medium | AI ambient scribe, medical dictation, note generation, and clinician-reviewed documentation | 5 official sources | Review profile |
| Twofold Health | Clinical documentation and scribes | Lower to medium | AI medical scribe for structured clinical notes, therapy notes, and encounter documentation | 3 official sources | Review profile |
| TORTUS | Clinical documentation and scribes | Lower to medium | AI medical scribe for consultation notes, transcripts, codes, and NHS-aligned documentation workflows | 3 official sources | Review profile |
| Aidoc | Medical imaging and radiology | High | Radiology triage, scan analysis, care-team activation, and enterprise AI orchestration | 4 official sources | Review profile |
| Viz.ai | Medical imaging and radiology | High | AI-powered care coordination around suspected disease detection and specialist activation | 4 official sources | Review profile |
| Ferrum Health | Medical imaging and radiology | High | Clinical AI governance suite for deploying, monitoring, validating, and managing imaging and other clinical AI models across existing infrastructure | 4 official sources | Review profile |
| Blackford Platform | Medical imaging and radiology | High | Enterprise radiology AI orchestration, relevancy routing, curated marketplace access, deployment monitoring, and AI application management | 4 official sources | Review profile |
| Brainomix 360 Stroke | Medical imaging and radiology | High | AI-enabled CT, CTA, MRI, and mobile stroke workflow support for suspected acute stroke assessment and transfer decisions | 5 official sources | Review profile |
| Qure.ai | Medical imaging and radiology | High | Chest X-ray, CT, lung cancer, tuberculosis, and stroke imaging workflows | 4 official sources | Review profile |
| Rad AI | Medical imaging and radiology | Medium to high | Radiology report drafting, impression generation, and reporting workflow automation | 3 official sources | Review profile |
| Cleerly | Medical imaging and radiology | High | AI-enabled coronary CT angiography and plaque analysis | 5 official sources | Review profile |
| Elucid PlaqueIQ | Medical imaging and radiology | High | AI-enabled coronary CTA plaque composition and lesion-level plaque analysis | 5 official sources | Review profile |
| LumineticsCore | Medical imaging and radiology | High | Autonomous AI diabetic retinopathy detection from retinal images at the point of care | 4 official sources | Review profile |
| Eyenuk EyeArt | Medical imaging and radiology | High | Autonomous AI diabetic retinopathy screening from color retinal fundus images | 5 official sources | Review profile |
| RapidAI | Medical imaging and radiology | High | AI-powered imaging triage, quantification, disease detection, and care-team workflow support | 6 official sources | Review profile |
| Heartflow | Medical imaging and radiology | High | AI-powered coronary CTA analysis, FFRCT physiology analysis, plaque analysis, and coronary roadmap workflows | 6 official sources | Review profile |
| Ultromics EchoGo | Medical imaging and radiology | High | AI-assisted echocardiography analysis for HFpEF detection support and cardiac workflow reporting | 4 official sources | Review profile |
| Gleamer BoneView | Medical imaging and radiology | High | AI-assisted fracture detection and trauma X-ray second-reader workflow support | 4 official sources | Review profile |
| iCAD ProFound AI | Medical imaging and radiology | High | AI-assisted breast cancer detection, mammography case scoring, density assessment, and short-term risk workflow support | 4 official sources | Review profile |
| ScreenPoint Transpara | Medical imaging and radiology | High | AI-assisted breast cancer detection, density assessment, temporal comparison, and mammography workflow support | 3 official sources | Review profile |
| Koios DS Breast | Medical imaging and radiology | High | AI-assisted risk assessment and computer-aided diagnosis support for breast ultrasound lesions | 4 official sources | Review profile |
| Subtle Medical | Medical imaging and radiology | High | AI-powered MRI and PET image enhancement, denoising, acceleration, and synthetic imaging workflow support | 6 official sources | Review profile |
| Lunit | Medical imaging and radiology | High | AI cancer screening, breast imaging, chest X-ray, precision oncology, and pathology biomarker workflows | 3 official sources | Review profile |
| annalise.ai | Medical imaging and radiology | High | Chest X-ray, non-contrast head CT, radiology triage, decision support, worklist prioritization, and draft reporting support | 4 official sources | Review profile |
| CureMetrix | Medical imaging and radiology | High | AI-assisted mammography worklist triage and breast-screening workflow prioritization | 3 official sources | Review profile |
| GE HealthCare Caption AI | Medical imaging and radiology | High | AI-guided cardiac ultrasound acquisition and automated ejection-fraction support on compatible GE HealthCare ultrasound systems | 4 official sources | Review profile |
| Butterfly iQ3 | Medical imaging and radiology | High | Handheld point-of-care ultrasound with AI-enabled workflow software and gestational-age AI tooling in eligible settings | 4 official sources | Review profile |
| Pearl Second Opinion | Medical imaging and radiology | High | AI-assisted dental radiograph review, pathology detection, patient education, and 2D or 3D dental image analysis | 5 official sources | Review profile |
| Overjet | Medical imaging and radiology | High | FDA-cleared dental X-ray analysis, caries support, bone-level measurement, image enhancement, and dental workflow automation | 6 official sources | Review profile |
| VideaAI | Medical imaging and radiology | High | Dental X-ray AI for clinical assist, patient education, caries and periodontal findings, and practice workflow insights | 4 official sources | Review profile |
| Paige | Digital pathology | High | AI-assisted digital pathology and prostate cancer detection support | 2 official sources | Review profile |
| PathAI | Digital pathology | High | Digital pathology image management, AI algorithms, quality control, and lab workflow | 4 official sources | Review profile |
| Ibex Medical Analytics | Digital pathology | High | AI-powered pathology workflows for cancer detection, grading, biomarker support, and structured reporting | 6 official sources | Review profile |
| Proscia | Digital pathology | High | Digital pathology image management, AI application deployment, model development, and lab workflow orchestration | 6 official sources | Review profile |
| Aiforia | Digital pathology | High | AI-assisted digital pathology suites for cancer diagnostics, quantitative image analysis, and case-level pathology reporting | 6 official sources | Review profile |
| Mindpeak | Digital pathology | High | AI-assisted tissue image analysis for breast biomarkers, PD-L1, HER2, tumor detection, and pathology workflow support | 4 official sources | Review profile |
| Aignostics | Digital pathology | High | Research-use digital pathology foundation-model analysis for H&E tumor microenvironment profiling and quantitative spatial metrics | 3 official sources | Review profile |
| Lumea | Digital pathology | High | Integrated digital pathology workflow with tissue-handling tools, FDA-cleared viewer, LIS-enabled case management, AI ecosystem access, and molecular test ordering | 5 official sources | Review profile |
| Visiopharm | Digital pathology | High | AI-driven precision pathology image analysis, biomarker scoring, diagnostic decision support APPs, research analysis, and workflow integrations | 5 official sources | Review profile |
| Tribun Health | Digital pathology | High | CaloPix image management, digital slide viewing, AI app integration, telepathology, archive workflow, and pathology platform modernization | 4 official sources | Review profile |
| DoMore Diagnostics Histotype Px Colorectal | Digital pathology | High | AI-powered digital biomarker for stage II and stage III colorectal cancer outcome prediction from routine H&E histology slides | 4 official sources | Review profile |
| Regard | Clinical operations and revenue cycle | Medium to high | Clinical insights from EHR data, pre-visit documentation, and missed-condition surfacing | 3 official sources | Review profile |
| Bayesian Health | Clinical operations and revenue cycle | High | Real-time EHR-based clinical intelligence, patient risk monitoring, early warning, care-pathway activation, and performance reporting | 4 official sources | Review profile |
| Fathom | Clinical operations and revenue cycle | Medium | Autonomous medical coding and coding automation | 3 official sources | Review profile |
| CodaMetrix | Clinical operations and revenue cycle | Medium | Contextual coding automation and medical coding performance improvement | 3 official sources | Review profile |
| SmarterDx | Clinical operations and revenue cycle | Medium | Clinical AI for revenue integrity, prebill diagnosis review, charge validation, denials appeals, and note-level revenue intelligence | 4 official sources | Review profile |
| Waystar AltitudeAI | Clinical operations and revenue cycle | Medium | AI-powered healthcare payment and revenue cycle automation across financial clearance, clinical integrity, claims, denials, and reporting | 3 official sources | Review profile |
| Tennr | Clinical operations and revenue cycle | Medium | Agentic patient-flow automation for referrals, orders, document intake, eligibility, prior authorization, triage, and outreach | 4 official sources | Review profile |
| AKASA | Clinical operations and revenue cycle | Medium | Generative AI for revenue cycle, coding optimization, CDI, authorization status, and claim status workflows | 4 official sources | Review profile |
| Notable | Clinical operations and revenue cycle | Medium | AI-powered healthcare automation for patient access, intake, authorization, scheduling, and administrative workflows | 4 official sources | Review profile |
| Qventus | Clinical operations and revenue cycle | Medium | AI-powered healthcare operations automation, inpatient capacity, surgical growth, perioperative coordination, and operational assistants | 3 official sources | Review profile |
| LeanTaaS iQueue | Clinical operations and revenue cycle | Medium | AI and machine-learning capacity management for operating rooms, infusion centers, inpatient flow, scheduling, and hospital operations | 5 official sources | Review profile |
| Iodine AwareCDI | Clinical operations and revenue cycle | Medium to high | AI-powered clinical documentation integrity, mid-revenue-cycle review, condition capture, coding support, and CDI prioritization | 3 official sources | Review profile |
| Cohere Health | Clinical operations and revenue cycle | Medium to high | AI-powered prior authorization, utilization management, payment integrity, clinical policy review, and payer-provider collaboration | 4 official sources | Review profile |
| Xsolis Dragonfly | Clinical operations and revenue cycle | Medium to high | AI-powered utilization management, medical-necessity review, concurrent authorization, discharge planning, denial prevention, and payer-provider collaboration | 5 official sources | Review profile |
| Hippocratic AI | Patient access, triage, and agents | Medium to high | Generative AI healthcare agents for outreach, patient engagement, and operational tasks | 3 official sources | Review profile |
| Infermedica | Patient access, triage, and agents | High | Symptom checking, preliminary symptom analysis, patient triage, and navigation APIs | 3 official sources | Review profile |
| Ubie | Patient access, triage, and agents | High | AI symptom checking, possible-cause reports, patient education, and care-seeking guidance | 4 official sources | Review profile |
| Hyro | Patient access, triage, and agents | Medium | Healthcare AI agents for call center automation, scheduling, patient support, and conversational intelligence | 3 official sources | Review profile |
| Infinitus | Patient access, triage, and agents | Medium to high | AI agents for healthcare calls, benefit verification, prior authorization follow-up, patient onboarding, affordability, adherence, and provider or payor outreach | 4 official sources | Review profile |
| Artera Harmony | Patient access, triage, and agents | Medium | AI-enabled patient communications, messaging orchestration, self-scheduling, intake, billing outreach, forms, and voice or text agents | 4 official sources | Review profile |
| Fabric | Patient access, triage, and agents | Medium to high | Care access platform for intake, triage, routing, virtual care, scheduling, and conversational AI | 3 official sources | Review profile |
| Corti | Patient access, triage, and agents | Medium to high | Healthcare AI agent framework, speech-to-text, coding support, documentation generation, and workflow-specific clinical agents | 3 official sources | Review profile |
| Sully.ai | Patient access, triage, and agents | Medium to high | AI healthcare agents for documentation, receptionist workflows, triage roles, coding, EHR integration, and developer-facing clinical-note APIs | 2 official sources | Review profile |
| Memora Health | Patient access, triage, and agents | Medium to high | AI-enabled care journeys, two-way texting, symptom management, patient-reported outcomes, check-ins, education, and escalation to care teams | 4 official sources | Review profile |
| Ada Health | Patient access, triage, and agents | High | AI-powered symptom assessment, care navigation, digital triage, clinical handover, and population insights | 4 official sources | Review profile |
| Mediktor | Patient access, triage, and agents | High | AI-based symptom assessment, digital triage, care routing, patient assistance, and LLM-enhanced medical-agent workflows | 5 official sources | Review profile |
| Luma Health Navigator | Patient access, triage, and agents | Medium to high | AI-powered patient self-service, appointment changes, refill requests, voice-to-SMS continuity, multilingual access, and operational AI workflows | 5 official sources | Review profile |
| Clearstep Smart Care Routing | Patient access, triage, and agents | High | AI chat and voice triage, symptom assessment, care navigation, scheduling handoff, and white-labeled digital front door routing | 5 official sources | Review profile |
| Syllable Healthcare Agents | Patient access, triage, and agents | Medium to high | AI agents for appointment scheduling, patient verification, waitlist management, referral processing, call routing, outbound reminders, and EHR-connected patient workflows | 5 official sources | Review profile |
| Prenosis Sepsis ImmunoScore | Precision medicine and data | High | FDA-authorized AI diagnostic and predictive sepsis risk assessment using EHR, vital-sign, demographic, laboratory, and biomarker inputs | 4 official sources | Review profile |
| Anumana ECG-AI | Precision medicine and data | High | FDA-cleared ECG-AI algorithms for identifying cardiovascular risk signals from standard 12-lead ECG workflows | 6 official sources | Review profile |
| Tempus | Precision medicine and data | High | AI-enabled precision medicine, multimodal data, diagnostics, and clinical trial support | 5 official sources | Review profile |
| SOPHiA GENETICS | Precision medicine and data | High | AI-powered genomic, radiomic, and multimodal data analysis through the SOPHiA DDM platform | 3 official sources | Review profile |
| Guardant InfinityAI | Precision medicine and data | High | AI-enabled precision oncology data exploration, cohort analysis, molecular pattern discovery, and real-world evidence workflows | 3 official sources | Review profile |
| ArteraAI Prostate | Precision medicine and data | High | AI-enabled digital pathology and clinical-data test for prostate cancer prognosis, therapy-benefit prediction, and treatment-intensity personalization | 5 official sources | Review profile |
| Unlearn | Precision medicine and data | High | AI-generated digital twins for clinical trial design, control-outcome forecasting, synthetic control comparisons, and statistical power planning | 4 official sources | Review profile |
| Owkin K Pro | Precision medicine and data | High | Agentic AI for biomedical research, multimodal patient data analysis, target prioritization, biomarker validation, and drug-development decisions | 3 official sources | Review profile |
| Caris Life Sciences | Precision medicine and data | High | AI-enabled molecular profiling, precision oncology insights, and tumor board reporting | 3 official sources | Review profile |
| Flatiron Assist | Precision medicine and data | High | EHR-integrated oncology clinical decision support, treatment pathways, biomarkers, trials, and prior authorization support | 2 official sources | Review profile |
| Truveta | Precision medicine and data | High | AI-supported real-world data analytics, cohort building, regulatory-grade evidence generation, and natural-language research assistance | 6 official sources | Review profile |
| Deep 6 AI | Precision medicine and data | High | AI-supported cohort discovery, clinical trial matching, protocol feasibility, patient identification, and real-world data extraction | 4 official sources | Review profile |
| Dyania Health Synapsis | Precision medicine and data | High | AI-assisted chart review, clinical trial screening, protocol matching, registry abstraction, and real-world data extraction from medical records | 4 official sources | Review profile |
| TriNetX | Precision medicine and data | High | Real-world data network, AI-supported cohort discovery, protocol feasibility, site identification, and clinical trial recruitment planning | 4 official sources | Review profile |
| Medidata AI | Precision medicine and data | High | AI-supported clinical trial planning, protocol optimization, trial risk monitoring, data quality workflows, synthetic control arms, and integrated evidence | 4 official sources | Review profile |
| ConcertAI | Precision medicine and data | High | Oncology-focused real-world data, generative and predictive AI, trial feasibility, trial screening, commercial insights, and care-quality analytics | 3 official sources | Review profile |
| Aetion Evidence Platform | Precision medicine and data | High | Real-world evidence generation, data preparation, cohort definition, causal analytics, regulatory-grade study workflows, and AI-assisted variable or subgroup work | 4 official sources | Review profile |
| nference nSights | Precision medicine and data | High | AI-assisted multimodal real-world data exploration, cohort analysis, clinical research insights, drug development support, and predictive model development | 4 official sources | Review profile |